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ABSTRACT
Contraceptive advertising and use is a widely accepted practice within North America, and yet 
has received little attention within the scope of marketing research. For a mass consumption 
product considered to be highly private and individualized yet tied to significant social, political, 
and environmental outcomes, it is important to understand how these messages and outcomes are 
interpreted at the individual level of the consumer. The current study was undertaken to explore 
the relationship between consumer identity and contraceptive use; how user identities are 
constructed in contraceptive advertising and how this impacts consumers; and the ways in which 
social agents like healthcare providers influence consumer health identities and contraceptive 
uptake. Semi-structured interviews were conducted with seventeen community-based 
participants and five healthcare providers to gain a better understanding of the intrapersonal and 
interpersonal dynamics that impact consumer perceptions of contraceptives and decisions to 
incorporate contraceptives into their reproductive plans. Using a grounded theoretical approach, 
the findings resulted in a theoretical framework that outline the key social agents and identity 
narratives that are reproduced within these social agents that directly inform consumer health 
identities, beliefs, and contraceptive use. Peers, healthcare providers, parents and partners were 
identified as primary social agents that informed consumer health identities and contraceptive 
use, and are fed by larger cultural scripts that are enacted through media and advertising. The 
concepts of autonomy and control emerged in participant accounts as diametric, or oppositional 
identity narratives that are reproduced within the level of each social agent and result in conflict 
that women must negotiate. As a result of this conflict, women develop perspectives and 
practices that inform their self-concepts around their health which then dictate their contraceptive 
use and larger contraceptive beliefs. The findings present an agenda to pivot contraceptive 
marketing away from traditional advertising strategies to a social marketing approach that 
incorporates stakeholders including healthcare providers and public health bodies in promoting
transparency, ethicality, and consumer agency in contraceptive use.
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After the U.S. presidential election of Donald Trump in 2016, it was reported that
appointments for installations of intrauterine devices (IUDs), a method of long-acting reversible 
contraceptive (LARC), skyrocketed at Planned Parenthood clinics across the United States 
(Dusenbery 2019).  For what reason did droves of women, some of which may have already been 
users of some method of contraception decide at that point to incorporate the IUD into their 
reproductive plan? For many, it was fear that President Trump would repeal the Affordable Care 
Act that provided health and medical support to Americans for a significantly reduced or covered 
cost (Dusenbery 2019; Wu et al. 2016). Currently the IUD is promoted as the most effective 
long-term method of contraceptive available as the most recent addition to the suite of 
contraceptives that include synthetic options like the subdermal implant, oral contraceptive (OC), 
the vaginal ring, emergency contraception, hormonal patch, and the hormone injection; and non- 
synthetic versions such as condoms, withdrawal and cycle tracking (Dusenbery 2019; Wu et al. 
2016). The high effectiveness and dependability of IUDs may qualify them the safest investment 
for a woman to make while waiting out a tumultuous political climate. Beyond election 
outcomes, for what other reasons are more women incorporating contraceptive technology into 
their reproductive plans?
A key historical consideration may explain contraceptive use as coinciding with shifts in 
social roles over time: more women are choosing to defer child-bearing and family planning, 
while others are choosing to not have children at all (Hill 2019; Watkins 2012). The introduction 
of the synthetic oral contraceptive in 1960 marked a milestone for female autonomy over their 
bodies, making it possible for women to reliably and effectively control their reproductive 
capacities in pursuit of career and educational goals (Hill 2019; Tone 2006). National birth rate 
trends are indicative of this social shift: the 2018 birth rates in Canada show an average of 10 
births per 1,000 in a population, compared to the rate of 26 births per 1,000 in 1960 when 
contraception was first launched (Statistics Canada 2020). Birth rates are also increasing in pace 
with maternal age, where more Canadian women are having children in their early thirties 
compared to women in their mid- to late-twenties (Statistics Canada 2020). The role of 
contraceptives cannot be understated: not only has this technology contributed to significant 
shifts in demographic and birth rate trends, but it has also impacted the visibility and 
employment rates of women in the Canadian workforce and employment markets around the 
world (Hill 2019).
The social aspects of contraceptive use are only one side of the coin.  Contraceptive use is 
a deeply personal and nuanced form of consumption in both men and women. For women 
especially, contraception assumes a larger role in their reproductive health management as they 
are consumed bodily either by ingestion or insertion for the purposes of unplanned pregnancy 
prevention, among other goals.  Contraception embodied, then, becomes a part of the female 
identity (Kissling 2013; Sanabria 2014). Women can choose to use one method over another or 
not use contraception at all, and they will continuously negotiate these choices over the course of 
their reproductive lives. These decisions, in turn, are informed by a web of overlapping 
individual, social and cultural dynamics like the U.S presidential election, for example. The 
current COVID-19 global health crisis is another scenario that, like governmental changes, may 
have unique and significant implications for contraceptive use among populations. Where
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phenomena like a pandemic can unilaterally shift personal health practices, healthcare services, 
and the wider social and cultural fabric of a population, these outcomes may have a combinatory 
effect on the reproductive decisions of women and families.
It is these factors: the individual and social elements that inform contraceptive use, the 
administration effects of new contraceptive options in the suite of available (and long- 
established) methods, and the consumption patterns of contraceptive methods altogether that are 
of interest from a marketing lens. Contraceptive marketing primarily occupies the realm of
direct-to-consumer (DTC) drug advertising by the pharmaceutical industry and bridged by
clinician prescriptions (Wu et al. 2016). Where contraceptive advertising was historically limited 
to physicians, the approval of DTC advertising in the 1980s allowed for companies to increase 
their marketing scope directly to their target consumer audience (Watkins 2012). During this 
time, contraceptive technology also expanded where additional formulations of OCs were 
produced and the hormone shot Depo-Provera, vaginal ring and implant were introduced to 
consumer markets (Watkins 2012). The tech boom in the 1990s and early 2000s has had the 
effect of an information Renaissance for reproductive and sexual health resources for consumers 
as well. As a result, women today have more access to contraceptive information and product 
choices than previous generations. However, this means that women are more accessible from an 
industry standpoint and will be exposed to significantly more marketing messages and media 
compared to previous generations (Watkins 2012; Wu et al. 2016).
The transition from a limited to public promotion of contraception is interesting - 
contraceptives can be categorized as ‘private goods’, much like dental floss, deodorant or 
laxatives. Individuals consume these items in private on the basis that they offer some benefit to 
their overall health or appearance specifically, and to their identity generally (Smith 2007); yet 
these objects fit for personal consumption receive the same promotional mix as do more public 
goods like clothing and cars. How does contraception marketing so brazenly promote 
consumption of such a uniquely private material good? Conversely, how do individuals perceive 
of these marketing messages and incorporate them into their own identity?  While women today 
may have a surplus of contraceptive options to consider, most still require physician intervention 
and, in the case of LARCS and injectables, clinical administration. For this reason, it is important 
to understand the role of healthcare providers as intermediaries for contraceptive marketing and 
access through a marketing lens.  Contraceptive use is first and foremost an individual decision; 
however, it is also one that is often made in collaboration with other stakeholders like partners 
and healthcare providers. In this context, the marketing messages that women will encounter and 
negotiate are twofold: from external advertising (print, TV and digital ads) and in the settings of 
her physician’s office. How healthcare providers disseminate industry advertising messages will 
inform how they approach patient consultations for contraceptive access. If a healthcare provider 
is a contraceptive user herself, she occupies the dual role of consumer and practitioner in her 
work. The link between external actors and private consumption raises another observation: 
What role do social agents like healthcare providers play in constructions of individual identity 
and contraception use?
Both consumer and provider perceptions on contraceptives and contraceptive advertising
are an important avenue of exploration for marketing research in general as much of the existing 
research has occurred in the disciplines of public health, medicine, psychology and feminist 
studies, among others. This gap in marketing research on contraceptives may be explained by 
trends in DTC advertising expenditures, where prescription medications for managing
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cholesterol, mood disorders, and even erectile dysfunction receive significantly higher ad spend 
at more than $3 billion USD for each drug class (Wu et al. 2016). DTC advertising for 
contraceptives, by comparison, accounts for a fraction of the total ad spend among the 
prescription drug classes (Wu et al. 2016). As research and advertising comprise a symbiotic 
relationship in marketing science, this would suggest that contraceptives are receiving less ad 
spend because they are receiving less research focus. This supports the mounting public criticism 
of the lag in developments for contraceptive technology where most current methods continue to 
rely on dated pharmacological properties that are more than fifty years old (Watson 2012). These 
findings in conjunction with the trending decline in birth rates suggest that there is an 
opportunity to expand understanding on the role of contraceptive marketing on individual 
reproductive decisions and their larger impact on consumer health identities.
Understanding contraceptive patterns and uptake are important from a marketing and a 
public health perspective: how and why women ascribe particular values or attitudes towards 
their reproductive health can have cascading effects for the community and population at large. 
Contraceptive use in and of itself can have medical, economic, environmental, social and cultural 
impacts (Hill 2019; Tone 2006). This places contraceptive access and use as an ethical 
consideration beyond simply as a consumer product. The responsibility of marketers to consider 
contraceptive use in human contexts instead of solely by advertising rates and figures means that 
the discipline must consider contraceptive marketing for the greater social good and not only for 
commercial gain. How major global events including climate change, resource scarcity, 
economic fluctuations, political upheavals and pandemics influence contraceptive uptake and 
reproductive decision-making are also critical to examine from a marketing standpoint as these 
phenomena can have direct impacts on managerial and consumer decisions.
This study intends to explore how contraceptive marketing and advertising is currently 
framed towards consumers, how consumers interpret these marketing messages, how social 
agents shape consumer attitudes towards contraceptive use or non-use in their reproductive 
decisions, and finally how contraceptive use informs user identities as a whole. These areas of 
inquiry will be examined as the following research questions:
RQ1: In what ways does consumer identity inform contraceptive use?
RQ2: How are user identities constructed in contraceptive advertising and how does this impact 
consumers?
RQ3: How and in what ways do social actors like healthcare providers influence consumer
health identities and contraceptive use?
The following sections will begin with an overview of applicable marketing theory as it relates to 
contraceptive marketing research and a review of the existing literature will be conducted to 
assess extant research in contraception marketing to set the context for the current study.
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CHAPTER 2: LITERATURE REVIEW
2.1 Theoretical Background
How and to what degree individuals consume contraceptives can be tied to their view of 
themselves. Individual self-concept – the combination of qualities and beliefs an individual has 
about themselves and how they evaluate those qualities – is a key concept in consumer behaviour 
and marketing research (Solomon, Zaichowsky and Polegato 2011). A main question that arises 
with self-concept is to what degree it is focused internally (based on introspection and psyche) or 
externally (based on social indicators) (Reed 2002). This will also inform the belief in the degree 
to which self-concept changes over time, and in what capacity. In his analysis on the 
conceptualizations of self-concept among different psychological paradigms, Reed (2002) argued 
that consumer research on identity will adopt a different view of the internal and external 
attributes of self-concept depending on the particular theory applied. Self-concept is another way 
of understanding the elements that combine to form an individual’s identity. Identity in 
marketing, defined by Reed et al. (2012), is understood as “any [original emphasis] category 
label to which a consumer self-associates either by choice or endowment” (p. 312). From a 
consumer behaviour perspective, individual identity, as with self-concept, is not a fixed aspect, 
nor is it unidimensional. Rather, individuals can assume multiple identities or ‘selves’, where 
some identities remain stable over the life course (identifying as a daughter, South Korean, male) 
while other identities will fluctuate (a Roughriders fan, practicing yogi, Liberal) (Reed et al. 
2012). In this way, some identities may assume more importance than others in an individual’s
self-concept.
The fact that an individual possesses different identities or ‘selves’ at different levels of 
importance does not guarantee that they will necessarily respond to a marketing strategy or 
product aligned to a particular held identity (Reed 2002). Consumer behaviour is concerned with 
understanding the mix of different contexts to best align consumer identities with products that 
they will be likely to invest in. Of the identity-relevant principles Reed and colleagues proposed 
to guide future consumer behaviour research, four are applicable to contraceptive marketing. The 
identity salience principle stipulates that factors that increase the salience – the extent to which a 
particular identity is available and accessible in one’s working self-concept (Reed 2002) – of a 
particular identity will increase identity-congruent attitudes and behaviours (Reed et al. 2012). 
The identity association principle describes how stimuli associated with a positively-held identity 
will be processed more positively in turn and will activate additional identity-related content, 
while the identity relevance principle assumes that when intentional identity-related information 
is processed, it will influence behaviour and judgements that align with that identity (Reed et al. 
2012). Finally, the identity conflict principle describes that individuals strive to minimize 
conflict across their identities by adjusting the degree of salience of particular identities (Reed et 
al. 2012).
These principles are relevant for understanding the relationship between consumer identity 
and contraceptive use; however, a more apt explanation could be borrowed from the realm of 
archaeology, in Monica Smith’s (2007) application of ‘reflexive identity’ as a process in which 
an individual identity is informed by both “elements of self-awareness or self-construction that 
are not wholly public” (p. 413) in her examination of inconspicuous consumption practices of
non-display products. The principles and concepts proposed by Reed et al. (2012) and Smith
(2007) provide a comprehensive start at understanding consumer identity, however the focus
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within this study lies on individual identity management and response to specific external 
stimuli. A theoretical understanding of the social and cultural influences of identity and 
consumption is warranted.
As Reed (2002) argued previously, consumer research will need to incorporate a definition
of self-concept that is both individually and socially constructed. The definition of self-concept 
posed earlier clearly frames consumer identity at a micro-level of analysis but does not appear to 
incorporate at a macro-level the larger social and cultural factors that directly influence self- 
identity. Consumer decision-making on product consumption does not occur in a vacuum, devoid 
of any external factors; it is deeply informed by social and cultural stimuli that in turn influence 
different individual-held identities. Social identity theory thus incorporates the role of social and 
cultural elements that inform how one constructs their individual and social identities using 
motivational and subconscious processes (Reed 2002). Social identity theory essentially states 
that individuals self-categorize to a particular social or cultural identity like race or nationality, 
and will adopt certain processes (practices) to integrate those identities into their working self- 
concept. This will have implications for how individuals interpret marketing stimuli that is 
perceived as relevant to their respective social identity.
Bagozzi and Van Loo (1978) provided one of the earliest explorations into fertility and 
consumption in consumer research. A key concept in their analysis on the economic, sociological 
and social-psychological models of fertility consumption was role theory – the pattern of 
relationships defined by norms linking individuals to prescribed social positions, as well as 
defining the specific privileges, duties and obligations within those positions (Bagozzi and Van 
Loo 1978).  This theoretical approach incorporates sex and gender norms as they are integrated 
in early childhood development as the mechanism that shapes an individual’s social role and 
positioning in adulthood (Bagozzi and Van Loo 1978). Role theory is used to explain how 
fertility management behaviours in women are impacted by socially- and culturally-sanctioned 
expectations of their role as child-bearers and nurturers in family units (Bagozzi and Van Loo 
1978). While role theory in this study is defined in its explanations of fertility consumption in 
heterosexual marriages (Bagozzi and Van Loo 1978), it can be argued that it encompasses more 
than simply gendered and heteronormative expectations limited to partnerships.  Women today 
take on many different roles over their life course that may include such roles as student, 
working professional, political representative or caregiver to parents, among others.
Consumer culture theory takes both role theory and social identity theory further by 
incorporating both into a holistic appraisal of the relationships between consumers, culture and 
the market (Arnould and Thompson 2005). Marketing is not simply a unidirectional process of 
industry defining and producing goods that are subsequently consumed by individuals; rather, 
consumption practices are shaped by experiential and social phenomena and in how individuals 
construct and interpret their immediate world (Arnould and Thompson 2005). Consumer culture 
theory builds on the view of consumer goods as vessels of cultural meaning that extends both 
from the culturally-constituted world and individual consumers as proposed by Grant 
McCracken (1986). Culture is not only the lens by which the consumer views their world but is 
also the mechanism that shapes their actions and behaviours (McCracken 1986). In this sense, 
consumer culture theory describes a symbiotic relationship between markets, consumers and 
culture and attempts to understand how this relationship contextualizes consumption experiences 
and practices. Consumer culture theory is relevant to consumer identity and contraceptive 
marketing because researchers want to better understand how (female) consumers construct their
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contraceptive use, how they interpret the marketing and advertising media promoting 
contraceptive use and how they shape their identities around their contraceptive method choices.
Viewed through an economic lens, contraceptive marketing and contraceptive use 
incorporates a process of exchange, a phenomenon widely considered to be the theoretical 
foundation of marketing scholarship (Bagozzi 1975). With exchanges, two or more parties 
engage in a reciprocal relationship that is based on shared interests and outcomes (Bagozzi 
1975). Contraceptive marketing incorporates different levels of transactions or exchanges among 
three primary parties: the pharmaceutical company (or industry), healthcare providers and 
consumers. In what Bagozzi (1975) terms a complex circular exchange, consumers seek 
contraception to help manage their reproductive capacities, which they must acquire from a 
physician as a prescription and from pharmacists as the contraceptive product itself. Doctors and 
pharmacists receive monetary and other tangible benefits from promoting the products of certain 
pharmaceutical companies, as well as revenue to clinics from each patient consultation. The 
pharmaceutical companies advertise their product to healthcare providers and consumers 
simultaneously and receive revenue from the units prescribed out of health clinics and 
pharmacies. Consumers subsequently are exposed to the advertising campaigns of the company 
and are prompted by a call to action to a) consider their reproductive health management by 
incorporating the advertised product into their health practices, and b) to speak with their 
healthcare provider for more information and access to the product, continuing the cycle of 
exchange.
Much of the existing research focuses on these chains of exchange separately: in existing 
marketing literature, the focus is on pharmaceutical DTC advertising to providers and to 
consumers. In public health and other social science literature, the focus is on patient-provider 
relationships and consumer experiences with contraceptive use. There is an opportunity for 
marketing research to build on the work of public health to examine the intersections between 
marketing messages, consumers, and providers and how contraceptive knowledge is transformed 
at these intersections.
Current research focuses on the tangible elements of contraceptive marketing and 
consumption: when, which, how and in what ways contraceptive methods are used. Exchange, 
however, can incorporate both utilitarian and symbolic elements, or the transfer of 
“psychological, social or other intangible entities” (Bagozzi 1975, p. 36). The symbolic aspects 
of contraceptive advertising and use have been explored within the arenas of feminist and gender 
studies but have been lacking in marketing literature. In the context of a clinical setting, 
providers and patients engage in a series of transactions that involve not only exchange of a 
prescription, but exchanges of knowledge, experiences (shared or otherwise), and
implicit/explicit social and cultural norms and scripts. This perspective is worth exploring in 
greater depth, as understanding both the tangible and intangible elements that inform whether a 
consumer will adopt a particular contraceptive method will directly impact how receptive that 
consumer will be to a particular marketing strategy. Viewing both healthcare providers and 
consumers as mutual stakeholders combining their individual knowledge and experiences on 
contraception places this exchange in the camp of service-dominant logic (SDL), proposed by 
Vargo and Lusch (2010).
Contraceptive use differs from other gendered consumer products in that it is more closely 
aligned to consumer identity and self to the extent that it is physically internalized. Because of
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this, female contraceptive use requires individual knowledge and awareness of her body and her 
menstrual cycles that is both unique and critical to decisions regarding contraceptive uptake. This 
means that consumers bring to clinics a breadth of knowledge and experience that merges with 
the knowledge and experience of a healthcare provider in determining a course of action with 
contraceptive use. Viewed this way, patients become key parties to health service exchanges and 
not merely recipients of a product (or prescription). Service dominant logic (SDL) views 
marketing exchanges as not simply an exchange of goods but an exchange of knowledge, and 
shifts the role of consumers from recipients to co-creators and collaborators of this knowledge 
(Vargo and Lusch 2010). SDL recognizes that value in a product or service is determined by the 
beneficiary – the ‘value-in-context’ (p. 227)  in contraceptive use is derived from consumers 
themselves, which in turn dictates how and in what ways contraceptives are communicated and 
exchanged in other settings (Vargo and Lusch 2010).
While contraception may be considered a more personalized object of consumption
compared to other products like fashion (McCracken 1986), it is similarly embedded with social 
and cultural meanings that guide its use. Examining theories of identity (social identity theory, 
role theory), culture (consumer culture theory) and marketing (exchange theory, service 
dominant-logic) are necessary to establish a theoretical framework for contraceptive marketing, 
and can serve to guide further research in the discipline. There is opportunity to shift the role of 
contraceptive marketing beyond the narrow scope of DTC prescription drug advertising and into 
settings that align with public health initiatives and improving social welfare (Hastings and Saren 
2003). Understanding how individual identities, values and behaviours, and the role of healthcare 
providers and other social and cultural informants drive contraceptive use may help to guide 
marketing and healthcare research and strategy to improve communications, transparency and 
accessibility of contraceptive technology.
2.2 Contraception Marketing Conceptual Framework
Figure 1 below (on next page) outlines a guiding framework of the key concepts of 
contraceptive marketing discerned from current literature, and outlines how existing marketing 
messages construct the identity of users, product use, and the role of risk impacting each of these 
attributes. These concepts will be explored in turn.
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Figure 2.1 – Contraceptive Marketing Conceptual Framework
2.3 Contraception Types, Trends and Use
The most recent national publication on contraceptive use among Canadian women dates
to 2015, suggesting a large gap in knowledge on current contraceptive rates (Statistics Canada 
2015). The results of the Canadian Health Measures Survey (CHMS) from 2007-2011 indicated 
16% of women ages 15-49 used an oral contraceptive (OC) method for reproductive health 
management; however, limitations in the scope of contraceptive methods (only OCs were 
assessed) and sampling parameters (the survey did not include women in remote locations or 
those living on reserves or First Nations settlements) provide little in the way of comprehensive 
Canadian demographic data that reflect current trends in contraceptive technology and uptake 
like LARCs (Rotermann, Dunn and Black 2015). Alternatively, U.S national health publications 
may provide a more detailed assessment of contraceptive use patterns among American women. 
From 2015-2017, approximately 65% of American women within the same age range were using 
a method of contraception, where contraceptive use increased concurrently with age and where 
sterilization, OCs, LARCs (including the IUD and implant) and condoms were reported as the 
most frequently used contraceptive methods (Daniels and Abma 2018). Similar trends have been 
found in European and Australian studies with the inclusion of ‘withdrawal’ reported as one of 
the most common contraceptive methods (Baharadwaj et al. 2012; De Irala et al. 2011; 
Wigginton 2016; United Nations 2019). While useful for a population level of analysis, the 
findings from both Canadian and U.S national health databases provide only a snapshot of 
contraceptive usage patterns limited to the survey administration period and, like other health
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research, are constrained to the recall abilities and reporting accuracy of participants. The 
numerical data on consumer demographic variables such as race, education level and economic 
background in government publications provide limited context into how each of these variables 
impacts contraceptive use.
Despite the recent spike in IUD uptake, oral contraceptives continue to be cited as the most 
common method among users (Antonishak, Kaye and Swiader 2015 Bharadwaj et al. 2012; 
DeMaria et al. 2019; Rocca and Harper 2012; Sanabria 2014; Sundstrom, Billings & Zenger 
2016; Sundstrom et al. 2015). By and large, contraceptive marketing has been promoted 
primarily for its use in preventing unplanned pregnancies. However, pharmacological advances 
in contraceptive technology have resulted in additional benefits in their use that include curing 
acne, controlling moods, reducing cramping and heavy periods, or mitigation of other medical 
conditions like endometriosis or recurring migraines (Ebeling 2011; Judge et al. 2017; Watkins 
2012). That contraceptive use could offer multi-symptomatic solutions was the impetus for the 
advertising push to market contraceptives as ‘lifestyle drugs’, and a prioritization towards 
synthetic contraceptive types by providers and consumers (Watkins 2012). It is unsurprising then 
that non-hormonal methods – with the exception of condoms - like withdrawal or natural family 
and cycle tracking methods have received little marketing attention. Instead, most research 
continues to focus on more modern synthetic methods such as the IUD and implant (DeMaria et 
al. 2019; Higgins, Kramer & Ryder, 2016; Mann & Grzanka 2018; Sundstrom et al. 2016; 
Sundstrom et al. 2015), emergency contraception (Colarossi, Billowitz & Breitbart 2010; 
Johnson et al. 2010), and the vaginal ring (Antonishak et al. 2015; Meier et al. 2019).
Individuals consume products based on two main objectives – for utilitarian reasons,
whereby the product or service satisfies a particular need, use or function, and where practicality
is the main benefit; or for hedonic reasons, where the goal of consumption is immediate 
gratification, satisfaction or pleasurable experiences (Botti and McGill, 2011; Holbrook and 
Hirschman 1982). Within these objective guidelines, promoting contraception as a solutions- 
focused product for pregnancy prevention as well as for secondary symptom management frames 
it as utilitarian in its purpose (Botti and McGill 2011; Holbrook and Hirschman 1982; Ledford 
2009; Watkins 2012). For non-hormonal contraceptive methods like condoms, the utilitarian 
aspects include not only pregnancy prevention but STD protection as well (Chiang, Chan and 
Milan 2018).
These ideas are substantiated in the literature: the majority of contraceptive research 
focused on contraceptive use for its utilitarian functions, where participant reasons for use 
included efficacy in pregnancy prevention (Bharadwaj et al. 2012; Sanabria 2014; Sundstrom et 
al. 2015; Sundstrom, Billings and Zenger 2016), protection from STDs (Baradwaj et al. 2012), 
birth spacing (Sundstrom et al. 2018), and secondary symptom management (De Irala et al. 
2011; Wigginton et al. 2016).  Financial cost and benefit, while not directly attributable to the 
physical goals of contraceptive use, did factor in as a consideration for uptake (Colarossi et al. 
2010; Daley 2014; Johnson et al. 2010; Sanabria 2014; Wigginton et al. 2016). While most 
participants valued the efficacy and physical benefits that come with uptake of a contraceptive 
method, the degree to which their economic freedom allowed them flexibility of choice 
significantly impacted their weighing of the balance between benefits and costs.
Few studies investigated participant experiences of contraceptive use for hedonic goals, or 
sexual experiences and enjoyment. This may be due to the fact that most of the contraceptive
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marketing and advertising continues to frame contraception for its practical, solutions-based 
function (Ledford 2009; Mann and Grzanka 2018; Sundstrom, Billings and Zenger 2016; 
Sundstrom et al. 2015).  Condom advertising stands as the sole contraceptive method marketed 
both for its utilitarian (pregnancy and STD prevention) and hedonic (pleasure enhancement, 
positive and safe sexual experiences) aspects (Chiang et al. 2018; Medley-Rath and Simonds 
2010). The degree to which contraceptive methods did or did not interfere with sexual 
experiences was often a lesser-cited reason for uptake by consumers (Baradwaj et al. 2012; 
Daley 2014; Higgins and Hirsch 2008). A study conducted by Higgins and Hirsch (2008) found 
effects on female sensation and well-being, effects on sexual spontaneity, desire for closeness, 
concern for partner’s pleasure and perceived security (from unplanned pregnancy) were cited by 
participants both in and outside of monogamous partnerships as key attributes that influenced 
which method of contraception was used.
These studies make clear that contraceptive use among consumers involves more than
simply reproductive risk management. Promoting synthetic contraceptives as a ‘lifestyle drug’
(Watkins 2012) has shifted the view of contraceptives as a unidimensional fertility solution to a 
product that can satisfy other physical, emotional or psychological needs in consumers. 
However, the majority of contraceptive marketing continues to reinforce the practicality and 
functionality of the methods while minimizing or omitting the hedonic, pleasurable benefits. 
Pleasure in use should not be restricted to a single method (condoms). Perhaps the hedonic 
elements of hormonal contraceptive uptake are implied, whereby regular contraceptive use helps 
to relieve pregnancy worries and control for other uncomfortable symptoms of menstruation, 
which opens individuals up to greater enjoyment in their personal and sexual lifestyles (Higgins 
and Hirsch 2008). As previous literature has shown, hedonic goals are not necessarily secondary 
or ‘afterthoughts’ for some consumers – it is a significant consideration in their contraceptive 
consumption behaviours. An area of opportunity for marketing research could involve expanding 
on the hedonic value of contraceptives and incorporating the ‘pleasure principles’ of 
contraceptive use into promotional strategies.
2.4 User Identity and Contraceptive Marketing
2.4.1   Individual - Goals:
To what extent contraceptive methods are incorporated into consumer health practices
involves many overlapping contexts. Individual goals and values will shape how consumers 
negotiate the suite of contraceptive methods available to them. Contraception ads frequently 
incorporate goal-relevant imagery into their promotional strategies by featuring models in 
various settings or activities like engaging in fitness, bonding with peers or partners, or 
prioritizing hobbies like music (Kissling 2013; Mann and Grzanka 2018; Watkins 2012). In this 
way, contraceptive ads promote an ideal self – a user that can attain her desired goals by 
consuming the product – or an identity-relevant self by featuring imagery that align with the 
demographic of interest (Reed et al. 2012).
Of the studies reviewed, unplanned pregnancy prevention was the most common and 
primary goal among consumers for contraceptive uptake (Bhattacharjee, Berger and Menon 
2014; Marston, Renado and Nyaaba 2018; Rocca and Harper 2012; Sundstrom, Billings and 
Zenger 2016; Sundstrom, Szabo and Dempsey 2018; Williamson et al. 2009). Other goals such 
as completing school and developing their careers were cited by participants as additional 
incentives for contraceptive uptake (Marston et al. 2018), although any alternative goals outside
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of pregnancy prevention were infrequent in the literature. It is interesting that many of the studies 
focused on contraceptive use among adolescent (Daley 2014) or college-age (DeMaria et al. 
2018; Higgins et al. 2016; Sundstrom et al. 2016; Wigginton et al. 2016) consumers but did not 
incorporate specific goal-related questions regarding contraceptive use outside of mitigating 
unplanned pregnancy. There is an opportunity for marketing research to expand on what other 
individual goals inform contraceptive use. For example, there is room to extend understanding 
on consumer financial and environmental goals tied to contraceptive consumption (Bagozzi and 
Van Loo 1978). The link between consumer goals and role theory is an important consideration 
for consumer behaviour research in contraceptive marketing. Goal-related contraceptive 
consumption is likely to differ depending on the life stage of the individual; students and young 
adults will have different short- and long-term goals compared to older or married adults that 
will differentially impact the degree of contraceptive uptake.
2.4.2   Autonomy and Control:
Contraceptive marketing is predicated on efficacy – the belief that a product will function
the way it is promoted – and especially on self-efficacy – an individual’s belief in their capacity 
to perform a behaviour to attain a desired outcome (Rosenstock, Strecher and Becker 1988). 
When women believe that they can successfully control their reproductive capabilities through 
consumption of a contraceptive method, they will be more inclined to do so. Consumer- 
perceived control and autonomy in consumption decisions have been reproduced in other studies 
involving explicit identity-targeted products and experiences (Bhattarjee et al. 2014; Botti and 
McGill 2011). Consumer self-efficacy emerged as a consistent theme in the contraceptive 
literature, with autonomy and control cited as one the main considerations for contraceptive 
method uptake (DeMaria et al. 2019; Marston et al. 2018; Sanabria 2014; Sundstrom et al. 2016; 
Sundstrom et al. 2015; Sundstrom et al. 2018). This narrative has been identified in the 
marketing strategies for contraception as well: while ads may cycle through different terms – 
empowerment, independence, control – the implied message of self-reliant fertility management 
endures over different brands, methods and organizations (Kissling 2013; Mann and Grzanka 
2018; Medley-Rath and Simonds 2010; Watkins 2012; Woods 2013).
‘Control’ was defined by participants in the reviewed studies as the individual capacity to 
manage somatic functions tied to menstrual cycles (Marston et al 2018; Sundstrom et al. 2018). 
Control was also cited as a factor in individual-held experiences regarding the scope of choice in 
contraceptive method options, where the degree of perceived agency was greater for users that 
had access to multiple (more than 2) contraceptive options versus fewer (2 or less) (Daley 2014; 
Higgins, Kramer and Ryder 2016; Johnson et al. 2010; Sanabria 2014). At a deeper level, 
consumer-perceived control impacts the specific type of contraceptive used, where methods like 
condoms and oral contraceptives provide users a more ‘hands-on’ approach to fertility 
management compared to other methods like injections, IUDs and subdermal implants (DeMaria 
et al. 2019; Higgins et al 2016; Wigginton et al. 2016). Contraceptive consumption, then, is a 
practice not only of physical, bodily control by consumers but of psychological control, the 
degree of which will differ among individuals.
2.4.3   Beliefs and Values:
Control and contraceptive use are deeply tied to perceptions of individual responsibility.
Most participants in previous studies were explicit about how contraceptive use contributed to
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beliefs about responsible behaviour (DeMaria et al. 2019; Fennell 2011; Sanabria 2014; 
Sundstrom et al. 2018). User beliefs in the adoption of a specific contraceptive method or the 
degree of efficacy of certain methods contributed towards a positive self-concept as a responsible 
individual, romantic/sexual partner and citizen (DeMaria et al. 2019; Reed 2002; Solomon et al. 
2011). Individual beliefs regarding the significance of menstrual cycles and female fertility in 
relation to contraceptive consumption was common area of tension among participants and their 
intentions towards contraceptive method uptake (Malefyt and McCabe 2016; Marston et al 2018; 
Sundstrom et al. 2018; Williamson et al. 2009)
While methods such as LARCs are promoted to lessen menstrual symptoms and even
stop cyclical bleeding altogether (Dusenbery 2019; Watkins 2012), this benefit was not wholly 
embraced by consumers. Many women believed that monthly periods were important and 
expressed concerns that the methods would negatively impact fertility (Bharadwaj et al. 2012; 
Daley 2014; Payne, Sundstrom and DeMaria 2016; Sundstrom et al. 2016; Sundstrom et al. 
2018; Williamson et al. 2009). While fertility fears and contraceptive use were primarily 
expressed regarding IUDs and implants, this was extended to other methods like the oral 
contraceptives (pill) and emergency contraception (Colarossi et al. 2010; Marston et al. 2018; 
Sanabria 2014; Williamson et al. 2009). While absent in much of the literature, religiosity may 
explain the significance that some users accord their menstrual cycles and can be a critical 
determinant of contraceptive use (Kusunoki et al. 2016; Ronis and LeBouthillier 2013). As 
previous studies have shown, responsibility, fertility and menstrual cycle ‘naturalness’ have been 
identified as key constructs in the self-concepts of contraceptive users. Consuming specific 
contraceptive methods contributes to a positive view of individuals as capable and responsible 
for their bodies and larger social impact while also maintaining balance in the physical and 
psychological aspects of their reproductive health.
2.4.4   Method ‘Fit’:
Consumer-held beliefs about fertility and contraceptive use informed the perceived ‘fit’ of
a particular contraceptive method as a reason for differential method uptake among consumers 
(Malefyt and McCabe 2016; Sanabria 2014; Wigginton et al. 2016). Contraceptive ‘fit’ for 
consumers was defined as the optimal physical comfort associated with using a method as well 
as the minimization or absence of any secondary effects such as bloating, bleeding, cramping and 
weight gain (Higgins and Hirsch 2008; Sanabria 2014; Sundstrom et al. 2016; Wigginton et al. 
2016; Williamson et al 2009). Consumers cited a sense of ‘knowing’ whether a contraceptive 
method was ‘working with or against their body’ (Wigginton et al. 2016, 260). This knowing 
was tied to perceptions of the physical and pharmacological properties of a contraceptive type. 
Despite all hormonal contraceptive methods sharing the same pharmacological properties 
(Watkins 2012), consumers differentially associated methods as congruent or incongruent with 
their self-identity based on their method of hormone delivery (Sanabria 2014; Sundstrom et al. 
2016).
LARC methods like the IUD and implant involve a more invasive, physician-administered 
incorporation into the body compared to self-administered methods like oral contraceptives. For 
this reason, consumers perceived of LARC methods as ‘foreign’ and incongruent with their 
embodied views of themselves and their prescribed method of fertility management (Payne et al. 
2016; Sundstrom et al. 2016). Alternatively, other users likened the ‘set-it-and-forget-it’
(Dusenbery 2019) aspects of IUDs to a freedom from the constant manual hormonal
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management that comes with using the pill, Nuvaring or hormonal patch (Sanabria 2014). In this 
way, consumer-held beliefs on contraceptive ‘fit’ are also informed by identity-related elements 
of control and autonomy that individuals wish to have over their fertility management and 
reproductive decisions. In summary, consumer identity incorporates both physical and 
ideological attributes in assessments of contraceptive method ‘fit’ and consumption.
2.4.5   Social/Cultural Consumer Identities – Gender Role:
Without question, individual goals, beliefs, autonomy and perceptions of method ‘fit’ with 
their body altogether are informed by social and cultural factors. Identity-relevant beliefs about 
contraceptive method use among individuals are informed by their external self – how they 
perceive of themselves in their respective social environment (Reed 2002; Solomon et al. 2011). 
The external self can assume many levels of abstraction and importance, spanning from 
individual identities as partners, family members, as part of a peer group, and extending to 
members of a community, nation or race (Arnould and Thompson 2005; Reed 2002). This 
extension of social/cultural identity in consumer contraceptive use was demonstrated in the 
literature. Contraceptive marketing is observed as overwhelmingly targeted toward female 
consumers (Fennell 2011; James-Hawkins, Dalessandro and Sennott 2019; Kissling 2013; Mann 
and Grzanka 2018; Medley-Rath and Simonds 2010; Watkins 2012). This is made obvious (and 
expected) in advertisements for contraceptives for female use like the pill, IUDs, implants, the 
hormone shot, emergency contraception and vaginal rings, while condom advertising is generally 
targeted to men and women (Chiang et al. 2018; James-Hawkins et al. 2019). In this sense, 
gender role identity is a key social construct in contraceptive consumption (Bagozzi and Van 
Loo 1978).
This gendered targeting may be why women in the studies reported beliefs of personal 
responsibility for contraceptive use. User-reported marital or relationship status did not change 
perceptions of responsibility in contraceptive uptake and management (Fennell 2011; DeMaria et 
al 2019; Higgins and Hirsch 2008; Marston et al. 2018; Wigginton et al. 2016; Williamson et al, 
2009). Only three of the reviewed studies incorporated both male and female perspectives on 
contraception use. Male views were generally supportive of receiving more information on 
different contraceptive options outside of condoms, discussing contraceptive use in partnerships, 
and of assuming personal responsibility in using gendered contraception like condoms (Fennell 
2011; Higgins and Hirsch 2008; James-Hawkins et al. 2019). These studies demonstrate the 
implications that identity-salience and identity-congruence strategies in contraceptive marketing 
have on consumer identity and reproductive behaviour.  As most contraceptive types are targeted 
towards females, males are often not primed nor encouraged to learn more about different 
methods for fertility management outside of condoms despite being key stakeholders in their 
successful use (Fennell 2011; Forehand, Deshpandé and Reed 2002; Reed et al. 2012).
In addition to assuming personal responsibility for contraceptive use in partnerships, 
women also reported a vested interest in the impacts of contraception on their partners’ 
preferences and experiences (Higgins and Hirsch 2008; Marston et al 2018; Williamson et al. 
2009). Partner requests or reports of interference of a contraceptive method were the most 
common reasons for women in relationships to change or discontinue a contraceptive method 
(DeMaria et al. 2019; Higgins and Hirsch 2008; Williamson et al. 2009). In this way, female 
responsibility incorporated not only her own vested interests in contraceptive use, but that of her 
partner. This self-identified responsibility of women to manage contraceptive use was echoed in
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male perspectives as well regardless of male-reported relationship status (Fennell 2012; James- 
Hawkins et al. 2019). Males also described personal conflicts with their degree of involvement in 
contraceptive use, acknowledging their desire to assume more responsibility in reproductive 
decision-making while also respecting the autonomy of women in managing their fertility needs 
(Fennell 2012; James-Hawkins et al. 2019). Female participants in the studies consistently 
oscillated between their individual and relationship identities, both of which informed their 
decisions regarding contraceptive method use or non-use. Women had to balance their individual 
goals with the relationship goals of satisfaction and trust to guide in their contraceptive uptake 
(Daley 2014). This balance becomes more significant when family and peer group identities are 
also incorporated.
2.4.6   Families and Peer Groups:
Exclusive of marital partnerships, users reported the degree to which membership in their 
biological and marital families impacted their identities as contraceptive users (Daley 2014; 
Marston et al. 2018; Williamson et al. 2009). Adolescents cited the influence of family as 
resources for fertility and contraceptive information and how the presence or absence of this 
information impacted constructions of themselves as contraceptive users (Daley 2014). The role 
of female matriarchs were reported as a valued resource for individual self-concepts around 
femaleness, fertility and responsible sexual behaviours (Daley 2014). Family attitudes toward 
contraceptive use were cited as a key factor in whether women adopted a synthetic method of 
contraception specifically or used any contraceptive method generally (Johnson et al. 2010; 
Marston et al. 2018.; Williamson et al. 2009). Familial role also impacted the degree to which 
female consumers perceived of their held responsibility for the continuity of bloodlines; this 
perception would extend to their perceived membership in extended families like in-laws 
(Marston et al. 2018; Williamson et al. 2009). This identity conflict determined the extent to 
which women would adopt certain contraceptive methods or other alternatives for fertility 
management.
Peer groups were reported as a primary resource for contraceptive information as well as 
barometers by which individual female identity was measured (Daley 2014; Johnson et al. 2010; 
Malefyt and McCabe 2016; Sundstrom et al. 2016; Sundstrom et al. 2015). In the absence of or 
as an alternative to parental guidance, peers can act as a support network for contraceptive access 
and use, particularly if the type or access method elicits anxiety or embarrassment like condom 
purchases (Ronis and Lebouthillier 2013) or requesting emergency contraception (Fallon 2010; 
Johnson et al. 2010). Often reported as a first point-of-reference before family, healthcare 
providers or other resources, peer groups and external peer influencers serve as sources of 
positive identity-shapers for contraceptive method uptake (Daley 2014; Sundstrom et al. 2016; 
Sundstrom et al. 2015) as well as negative identity-shapers to dissuade a particular method 
(Johnson et al. 2010). Research focused on promoting newer contraceptive methods like the IUD 
and implant (Sundstrom et al. 2016; Sundstrom et al. 2015) explored the use of young 
influencers and friends as identity-salient measures to encourage new user uptake. In this 
context, social identity theory (Reed 2002) and role theory (Bagozzi and Van Loo 1978) can 
explain how individual-perceived roles in family units as well as membership in peer groups 
shape contraceptive uptake or switching among contraceptive methods. A related area worth 
exploring would entail the effects of peer group polarization towards a specific contraceptive 
method and how users negotiate between the ideal versus actual identities in their contraceptive 
method uptake.
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2.4.7   Healthcare Providers:
More than all other providers, the physician-patient relationship is the most significant
from a consumer behaviour and contraceptive marketing standpoint. While direct-to-consumer 
(DTC) advertising has helped to promote consumer autonomy and empowerment by reducing 
physician reliance as another resource for contraceptive information (Watkins 2012), physicians 
continue to occupy a key role in consumer reproductive decision-making, specifically with 
contraceptive use. Since most contraception available today requires a prescription or clinical 
administration, physicians assume a triangulate partnership with industry and with patients in a 
contraceptive marketing framework. In the physician-provider relational context trust is 
paramount, and has been cited in multiple studies as a key determinant in contraceptive uptake 
among consumers (Adams et al. 2019; De Irala et al. 2011; Sundstrom, Szabo and Dempsey 
2018). Individuals want to trust that physicians will be well-versed in all contraceptive methods 
and will be able to advise on a best fit (DeMaria et al. 2019; Higgins et al. 2016; Sundstrom et al. 
2016). Trust is also tied to the belief that physicians will communicate with transparency and 
honesty in consultations and will always have the bests interests of their patients at heart 
(Sundstrom et al. 2018). In many cases, individuals will prioritize the recommendations of 
physicians over partner input in decisions regarding uptake of hormonal contraceptive methods 
(De Irala et al. 2011; Sundstrom et al. 2018; Zimmerman 2018).
Much like the relational closeness of friends versus acquaintances, the nature of the 
relationship between the physician and consumer is also important – interactions will be 
significantly different if a patient as a long-established family physician compared to transient 
physician visits in hospitals or walk-in clinic settings. The degree of physician influence on 
individual consumption decisions can serve as a source of empowerment for consumer health 
identities (Sundstrom et al. 2018) or a source of conflict in cases where prioritization of 
contraceptive attributes differ between physicians and patients (Higgins et al. 2016; Meier et al. 
2019; Payne et al. 2016; Sundstrom et al. 2016; Weisberg et al. 2013). Physician biases towards 
specific products or methods along with larger systemic healthcare biases towards specific 
groups or economic brackets can have significant impacts on consumer agency and autonomy in 
accessing a contraceptive method that meets her individual health needs and goals (Higgins et al. 
2016; Meier et al. 2019). For Black, Indigenous and Latina women especially, the remnants of 
historical government practices of population control and forced sterilization continue to fuel 
distrust of healthcare bodies and implicate decisions regarding their reproductive identities 
(Colarossi et al. 2010; Higgins et al. 2016; Meier et al. 2019). What happens when there is a 
disconnect between consumers and physicians? To what extent do consumers engage in 
supplemental contraceptive education and resource-seeking outside of clinical settings? In what 
circumstances do they seek other healthcare providers for contraceptive information, such as 
pharmacists or nurse practitioners?
Recent FDA changes to contraceptive drug access have given pharmacists a larger scope in 
prescribing and dispensing of contraceptives, making them key stakeholders in reproductive 
healthcare and information conduit for consumers seeking contraception (Maderas, Landeau and 
Taylor-McGee 2008; Colarossi et al. 2010). Pharmacists may also be considered a more 
approachable, less threatening healthcare provider and a preferred first point-of-contact for 
consumers as an alternative to seeing a physician (Colarossi et al. 2010). In cases where 
geographic location like small towns or settlements restrict consumers from accessing a 
physician, pharmacists may assume a central health role in contraceptive administration and
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counsel (Faris et al. 2010). Like physicians, however, pharmacists can also be subject to biases in 
communication and product provision (Sanabria 2014), and in rare circumstances can be barriers 
to consumer access to contraception by refusing to prescribe some contraceptive types (Maderas 
et al. 2008).
2.4.8   Race and Culture:
Gender role identity, religiosity and contraceptive use align closely to individual racial and 
cultural identities (Higgins et al. 2016; Marston et al. 2018; Williamson et al. 2009). This is most 
prevalent in studies of contraceptive use in developing countries (Marston et al. 2018; 
Williamson et al. 2009). Female participants in countries including Ghana, South Africa, 
Tanzania, Mali, Nigeria and Vietnam described contraceptive use as conflicting with their 
individual, marital and social identities (Marston et al. 2018; Williamson et al. 2009). 
Maintaining their identity as ‘good wives’ as well as managing expectations as child-bearers in 
marriages influenced the extent to which women adopted certain contraceptive measures 
(Marston et al. 2018). Males in these countries assumed a larger role in contraceptive decision- 
making and would often delegate the extent of contraceptive use and the type of method used 
(Williamson et al. 2009). Geographical differences in contraceptive method accessibility also 
restricted female autonomy of choice. Limitations existed by brand and by method; generally, 
women would have access to some version of oral contraceptive, emergency contraception and 
condoms (Marston et al. 2018; Sanabria 2014). Where one of these methods is predominantly in 
the control of men, women were left to choose between synthetic methods or less efficacious 
methods like ‘withdrawal’ (Marston et al. 2018).
Historical events involving the nefarious use of contraception must also be considered as it 
impacts racial and cultural identity. Government-funded measures to enforce population control 
in Indigenous, Black, Puerto Rican and other minority or economically-disadvantaged groups 
has left decades of trauma and distrust towards healthcare systems and the promotion of certain 
contraceptive methods among non-White users (Higgins et al. 2016; Kusunoki et al. 2016; Meier 
et al. 2019; Rocca and Harper 2012). This is especially prevalent in user attitudes toward LARCs 
and IUDs in particular (Higgins et al. 2016, Meier et al. 2019). Understanding the ways in which 
reproductive technology intended to liberate women was instead used against them based on the 
colour of their skin or their culture is critical for studies on sexual health and reproductive 
behaviours. That these perspectives endure today among minority groups is problematic; a 
contraceptive method that has significant medical and social benefits to female livelihood has 
been tainted and left out of consideration for some women. Future studies must consider how 
these historical contexts continue to shape minority opinions on contraceptive attitudes and use, 
and should incorporate these perspectives as guiding frameworks for future marketing and 
reproductive health campaigns that are culturally-inclusive and informed.
Cultural differences in perceptions of pharmaceutical method use have been demonstrated
in previous studies, whereby cultured views on health management often involved rejection of 
pharmaceutical treatments in favour of complementary and alternative medicines (CAMs) 
(Adams et al. 2019). Aside from critiques of contraceptive marketing on the gender-skewed 
promotional strategies, incongruence in identity-salient advertising of contraceptive methods 
may explain some of the racial differences in contraceptive method uptake (Higgins et al. 2016; 
Williamson et al. 2009). The cautioned view on pharmaceutical and synthetic treatments was 
demonstrated in the current studies on consumer identity research and contraceptive use in non-
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Western countries (Marston et al, 2018; Williamson et al. 2009). Culturally-informed individual 
beliefs on the significance of fertility and menstruation and the perceived risk of synthetic 
contraceptive use on fertility drove many women to consider other socially-accepted options like 
condoms (Rocca and Harper 2012), or ‘natural’ methods like withdrawal (described earlier), 
abstinence periods or traditional herbs and treatments (Marston et al. 2018; Williamson et al. 
2009). For consumers in non-Western countries, culture and custom significantly determines 
how contraception is used and how it is linked to identity. Cultural influence in Western 
countries like the U.S. was incorporated in some of the studies (Colarossi et al. 2010; Higgins et 
al. 2016), however there is an opportunity to explore this in more detail, especially in Canadian 
contexts that incorporate multi-ethnic and Indigenous identities.
2.4.9   Status:
Fertility, described earlier, not only informed individual identity in developing countries
but also to defined individual status (Marston et al. 2018; Williamson et al. 2009). Female social 
status in certain cultures directly implicated whether she used a particular contraceptive method, 
especially those that required pharmacist access (Marston et al. 2018; Williamson et al. 2009). 
Extramarital sex and unplanned pregnancy were viewed as a violation of social norms in some 
countries, much like the failure to produce (many, and in a timely manner) children in a marriage 
was another blight to cultural norms and expectations (Marston et al. 2018; Williamson et al. 
2009). In these scenarios, female consumers engaged in identity conflict management with their 
contraceptive use to satisfy their individual goals and fertility needs while maintaining the 
expectations that defined their social role (Marston et al. 2018; Reed et al 2012; Williams et al. 
2009). In this way, fertility is viewed as a form of currency for women – to be able to conceive is 
to guarantee their social rank and financial safeguards within marriages (Williamson et al. 2009). 
Subjective views of social status also informed what types of contraception were acceptable and 
not acceptable for use; for example, OCs require a larger financial investment over time and are 
normalized as daily method of reproductive health management, much like taking a daily 
multivitamin for general health benefits. Based on these factors, OC use is predominantly 
associated as a middle- to high-income method of contraception. Other method use may act as a 
blight to social status, which will be discussed in later sections.
While the relationship between identity status and contraceptive use was explicitly 
demonstrated in studies in African and Asian countries, it is worthwhile to consider how women 
in North America also tie their contraceptive use to a particular social status. Like some 
developed countries, financial wealth and security in North America are a metric of social status; 
it can be assumed that a female’s socioeconomic status will determine a) the suite of 
contraceptive methods that are accessible to her, and b) the amount of children she may choose 
to have and the flexibility of the timeframe with which to do so. Where those in a higher 
socioeconomic bracket may invest in more children versus those in lower socioeconomic levels, 
the inverse may also be true: where high socioeconomic status is tied to having less children 
compared to lower socioeconomic status, with a corresponding linearity between financial 
security and contraceptive accessibility. There is opportunity for this to be explored in more 
detail in future studies, especially in cities with a diversity of social wealth and income brackets.
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2.5 Contraceptive Marketing and Consumer Risk
Depending on the particular identity and identity-congruent beliefs and values, individuals 
will view ‘risk’ in different ways (Mandel 2003). In a study on identity and consumer risk- 
taking, Mandel (2003) demonstrated that the degree to which an individual would take a 
financial or social risk depended on whether they were primed with independent or 
interdependent cues. Those primed with independent cues were more likely to take a social risk 
versus a financial risk, whereas those primed with an interdependent cue reported the opposite 
(Mandel 2003). In this way, the degree to which a consumer allocates importance to a particular 
identity in their working self-concept will inform how they approach risk as well as the types of 
risk they will take (Mandel 2003). Within the existing contraceptive marketing literature, risk 
linked both user identity as well as the use outcomes for consumers. Contraceptive marketing 
frames risk in different ways: where private (commercial) ads focus mostly on female autonomy 
and empowerment and on risk avoidance indirectly, public health-related contraceptive ads are 
more explicit about individual risks (Mann and Grzanka 2018). However, consumer perceptions 
of individual versus social risks to contraceptive use can differ by geographic location. Of the 
studies conducted in North America and Europe, consumers prioritized risk in contraceptive 
use/non-use at an individual level. In African and Asian countries, consumers prioritized risk 
with contraceptive use at a social level (Marston et al .2018; Williamson et al. 2009).
Using the findings from North American studies, Figure 2.2 outlines the consumer 
stratification of risk with contraceptive use beginning at the individual level and expanding 
outward to a larger social contexts:
Figure 2.2 – Consumer Stratification of Risk
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For nearly all consumers, avoidance of unintended pregnancy and STDs were cited as both 
individual outcomes (aligned with their goals) and risks to mitigate by using contraception. 
Unexpected contraceptive side effects were cited as a risk with contraceptive use by participants 
in studies and a primary reason for method changes or discontinuation (Sundstrom et al. 2018; 
Wigginton et al. 2016). Individual perceptions of contraceptive side effects were formed as a 
result of their experiences with certain contraceptive methods, and generally were not found to 
be clearly communicated in advance of their uptake (Ledford 2009; Mann and Grzanka 2018). 
Unintended pregnancies specifically were linked to financial risk (Colarossi et al. 2010; Daley 
2014; Mann and Grzanka 2018; Williamson et al. 2009) especially among consumers outside of 
stable partnerships and in low-income or income precarious circumstances. Even within 
partnerships as with consumers in developing countries, hormonal contraceptive use in and of 
itself was considered a greater financial risk based on its perceived implications to fertility and 
potential consequences to the marriage, a key determinant of economic security (Marston et al. 
2018; Williamson et al. 2009). Feelings of shame and embarrassment were linked as a 
consequence of unintended pregnancies and STDs as well as financial windfalls tied to 
contraceptive use or misuse, and are classified as a standalone risk (Daley 2014; Williamson et 
al. 2009). Shame and embarrassment also impacted the identity-salience of contraceptive 
consumption whereby some women would avoid purchase of a particular type altogether as was 
often the case with emergency contraception (Colarossi et al. 2010; Johnson et al. 2010; 
Williamson et al. 2009). Unintended side effects like weight gain, acne, mood changes and 
irregular bleeding/cramping exacerbated perceptions of shame and embarrassment, impacting 
individual identities and often extending into personal relationships (Daley 2014; Wigginton et 
al. 2016).
Finally, risk of social stigma was an overarching consequence linking consumer identity
and contraceptive use. As described previously, socially-responsible women were perceived as 
those that adopted any regularized method of contraceptive use compared to women who used no 
methods; however the method of use also dictated which users were ‘more’ responsible based on 
social and cultural norms (Mann and Grzanka 2018; DeMaria et al. 2019). Using a more 
effective, long-acting method like the IUD or implant may promote greater identity-relevant 
perceptions of responsibility and reproductive control compared to using one-time methods like 
emergency contraception or ‘natural methods’ like withdrawal and cycle tracking (Mann and 
Grzanka 2018; Sundstrom et al. 2015; Sundstrom et al. 2016). Alternatively, in cultures with 
more traditional gender roles and norms, modern contraceptive use was tied to a negative social 
stigma and a rejection of female identity as chaste (outside of marriage) and obedient partners 
and child-bearers (Marston et al. 2018; Williamson et al. 2009).
Contraceptive use and consumer identity is at once an individual and social risk, however 
risk mitigation in one identity can appear to satisfy some of the risks of the other. Risk 
perception appears to be culturally linked, where individuals in collectivist countries will 
prioritize risk based on social identity compared to those from individualist countries who 
prioritize risk at an individual level. There is an opportunity to extend understanding on the 
social stigma linked to particular contraceptive methods and how this impacts contraceptive 
uptake. For social marketers, repairing the stigma of contraceptive types and endorsing an equal 
promotion of all contraceptive options in an “anything that works” as opposed to an “anything
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but” rhetoric of contraceptive uptake can help to promote healthy reproductive decisions and 
behaviours among a greater population rather than a select group.
In summary, the existing literature demonstrates that contraception marketing involves
more than simply product and brand promotion. It comprises three primary elements centered 
around user identities, product use and risk. User identities involve both individual (goals, 
autonomy/control, beliefs, method ‘fit’) and social/cultural factors (gender roles, peers and 
family, providers, race, status) that, singly and in combination, inform how contraception is 
perceived and consumed within user self-concepts. Contraceptive use has evolved beyond its 
initial purpose of preventing unplanned pregnancy and is consumed for other utilitarian reasons 
such as family spacing, menstrual symptom management or cessation, or as a treatment option 
for medical conditions. Alternatively, contraceptive consumption can also be used for hedonic 
purposes, to enhance sexual experiences and enjoyment. Finally, risk determines the extent to 
which individuals will or will not use particular contraceptives, or contraceptives generally. Risk 
assumes different outcomes, ranging from unplanned pregnancy, STDs or contraceptive side 
effects, financial windfalls, embarrassment/shame and stigma. Each of these elements of identity, 
use and risk are fluid in the context of individual consumption patterns and will assume different 




Taken together, the conceptual frameworks described earlier are grounded in a
constructivist paradigm that views meaning and experience as constructed by individuals and 
informed by social and cultural contexts (Braun and Clark 2013). The current study seeks to 
understand the ways in which identity drives contraception uptake, the contexts for changes to 
contraceptive use and how contraceptive advertising informs this practice of private 
consumption. Understanding these aspects involves incorporating the narratives of individuals as 
well as healthcare providers to understand the origins and nuances in individual attitudes and 
experiences with contraceptive use, and to understand the patterns of contraception that have 
implications from a marketing and public health standpoint. While quantitative analyses can tell 
us about the numbers and rates of contraceptive use that may be useful from a marketing 
analytics standpoint, only qualitative analyses can provide a richer understanding of the 
complexity and meaning behind individual contraceptive use. Unlike other mass-produced 
products like phones and TVs, fashion, cars or food, contraception use is not a ‘one-size-fits-all’ 
product. The fact that contraception is advertised as such may be problematic for prospective 
users with complex medical histories and health needs. Medical science has provided a portfolio 
of different synthetic contraceptive options for women in addition to other non-pharmacological 
options like condoms and natural family planning, and understanding how these options are 
incorporated into individual health decisions requires a deeper understanding than statistics alone 
can provide.
In this context, this study followed a qualitative method of inquiry to explore how identity 
frames and informs consumer uptake of contraception, how contraceptive marketing ads 
construct user identities, and the ways that healthcare providers impact consumer health 
identities and contraceptive use. Grounded theory is a well-established systematic approach to 
qualitative research and a best practice to understand a phenomenon through the lens and 
experience of individuals (Charmaz 2006). It was originally constructed as a response to 
criticisms regarding the validity and rigour of qualitative research compared to quantitative 
studies (Charmaz 2006). The outcome of a grounded theoretical approach is a theoretical model 
that is the result of a deep and immersive assessment of the data; theory ‘emergent’ from the data 
(Charmaz 2008). As there exists little research into the complexity of identity and consumption 
in marketing research, grounded theory is an ideal approach to understanding the complexities of 
this personal practice of healthcare consumption.
The emergent nature of a grounded theory methodology entails that an inductive approach
is applied when designing a study (Charmaz 2008). Specifically, researchers approach analysis 
without any pre-established themes or concepts; rather, they engage in the data with an open- 
ended approach and allow for themes and concepts to reveal themselves using techniques like 
close readings and constant comparisons of the data (Charmaz 2006). This level of analytical 
rigour, along with the processes of theoretical sampling and memoing are what makes grounded 
theory a reliable and valid qualitative approach. A common point of contention among 
researchers is whose grounded theory that a study adopts (Charmaz 2008). Much like the 
systematic nature of the method, the process of identifying which theorists’ – Glaser and Strauss 
(1967), Corbin and Strauss (1990) or Charmaz (2006) – version of grounded theory was applied 
is another process by which researchers must attend to ensure reliability and reproducibility of
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their research (Charmaz 2008). Each version of grounded theory shares the same overarching 
principles of data-driven theoretical development; however each differ in the degree of flexibility 
of application and the involvement of the researcher.
Glaser and Strauss (1967) intended grounded theory as a defined method of data collection 
and dissemination where the rigour was based in the process, while Charmaz (2006) has 
expanded this to include the researcher’s own epistemological assumptions and experiences as 
part of the data analysis. In this way, the researcher is not an impartial, objective audience to the 
research – rather, they bring their individual understanding and experience to the phenomenon of 
interest, as well as ideas and assumptions that inform how they interact with participants, frame 
questions, and determine the data of interest during analysis (Charmaz 2006). For this study, I 
chose to adopt Charmaz’s (2006) grounded theory for two reasons: first, how contraception is 
viewed and consumed is unique to every individual user, and is informed by a web of 
overlapping biological, social, political, environmental and structural contexts that shape each 
individual’s use; and second, I approach this study as a long-time contraceptive user. My interest 
in contraception is personal and social – it is a tool not only for health management but also for 
meeting certain individual and social goals or milestones. It is a critical tool for individuals to 
write their own life narratives that are no longer solely determined by their biological anatomies 
or ‘clocks’. The personal investment in this area of research allows me to adopt the lens of an 
‘insider’ – one that has insights and perspectives that may lend themselves to a more intuitive 
approach to contraceptive marketing research, to guiding the areas of inquiry within the research 
area, and building connection and rapport with participants.
3.2 SCPOR and Patient Partners
This study was undertaken in partnership with the Saskatchewan Centre for Patient
Oriented Research (SCPOR), a research organization led by the Canadian Institute of Health 
Research (CIHR). SCPOR operates under the vision of research that brings the patient 
experience to the fore. In this way, SCPOR helps to provide research funding and support for 
trainees in undertaking research that is patient-oriented in methodology and outcomes. The 
benefits of patient-oriented research are twofold: the systems of health research knowledge are 
no longer relegated to the authorities of researchers and academics alone but are expanded to 
include the ‘researched’; and the dissemination of the research is intended to be ‘by patients, for 
patients’ in a language that is inclusive and with outcomes that are realistic and directly 
implementable to patient groups. To help guide these research pursuits, patients themselves are 
involved as partners and members of the research team for all aspects of study development, as 
was the case with the current study.
My patient partner is a current student pursuing her Doctor of Pharmacy (Pharm.D.) at the 
University of Saskatchewan. She brings a unique lens the current study by occupying two 
worlds: as a pre-professional healthcare specialist with experience in the pharmacological and 
dispensation of pharmaceutical products like contraceptives, and as a consumer of contraception 
for many years. My partner was instrumental in the preparatory stages of research and assisted 
with recruitment of both patient participants as well as healthcare providers. She had valuable 
insights with the development and refinement of the interview guides as interviews progressed 
and was a key partner in data coding and analysis. Her perspectives were critical in unpacking 
the interview data of both patients and providers and helped to lay the connections between these 
stakeholders that informed development of the model.
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3.3 Content Assessment
To get a sense of how contraception is currently promoted to consumers and providers, a 
preliminary content assessment was conducted. I undertook an examination of popular consumer 
magazines to examine how contraception was currently being advertised. Based on the target 
female demographic, available readership data yielded Vogue, Cosmopolitan, Elle, Women’s 
Health, In Style, Vanity Fair and Harpers Bazaar as the most popular women’s lifestyle 
magazines based on print and digital circulation (Alliance for Audited Media 2020). 
Cosmopolitan and Vogue were determined to be the most reliable print source for contraception 
advertisements per monthly issue, and all ads were examined for DTC contraception 
advertisements over a one-month period. The sample included 12 issues in total between May 
2019 and May 2020 for Vogue and 10 issues total between May 2019 and May 2020 for 
Cosmopolitan, as I was unable to locate two issues.  The contraceptive ads were assessed by 
determining the contraceptive method being promoted, and the pictorial and verbal components 
were assessed to determine how user identities were portrayed. Key findings from this analysis 
found an exclusivity of contraceptive methods promoted in Vogue, where ads for the subdermal 
implant Nexplanon and emergency contraception Plan B were the only contraceptive products 
that were included in the sample.
Cosmopolitan demonstrated a wider variety of contraceptive ads for the non-hormonal IUD 
Paragard, the hormonal IUD brand Kyleena, Nexplanon and Lo Loestrine FE, an oral 
contraceptive brand. Paragard was featured significantly more per issue than the other methods. 
These results are bolstered by the DTC ad spend trends for contraceptive advertising as found by 
Wu and colleagues (2016). Only the Nexplanon ads featured models from different racial 
backgrounds; the majority of the models were young, white, and attractive, in keeping with 
findings from previous literature. The verbal components of the ads predominantly described 
features of the product itself, although older ad runs of Nexplanon found in the content 
assessment featured language framing user identity in predominantly positive and empowering 
contexts. These ads were used to guide interview questions and as supporting documents in 
participant data collection methods. The final ads that were selected for use in the interviews 
included a Nexplanon ad featuring actress Vanessa Hudgens, and a Plan B ad featuring a non- 
celebrity model. In addition to the print ads, a Youtube link for the most current Paragard TV 
commercial campaign was selected for participants to review prior to the interviews. The ads 
were chosen because they were the most current campaign ads for the contraceptive products as 
well as the most commonly occurring contraceptive ads in both Vogue and Cosmopolitan. Both 
print ads and a digital commercial ad were used to ensure diversity of products and advertising 
media, and to account for the different instances of ad exposure that consumers may encounter.
3.4 Setting and Participants
Ethics approval for the study was granted in October 2020 by the Behavioural Research 
Ethics Board at the University of Saskatchewan. Due to the ongoing COVID-19 pandemic, all 
recruitment and data collection were conducted under the University’s pandemic protocols. This 
entailed conducting the patient partner meetings, recruitment initiatives and data collection 
remotely. Participant recruitment proceeded in November 2020 after consultation and planning 
meetings with the patient partner. The population of interest for this study included women 
between the ages of 18 and 45 that were a) English-speaking; b) currently taking a or had taken a 
method of contraception within the previous six months; and c) currently sexually active or had
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been sexually active within the previous six months. Applicable methods of contraception 
included oral contraceptives, IUDs or subdermal implant, the vaginal ring (Nuvaring), hormone 
shots (Depo Provera), IUDs, emergency contraception (Plan B), the patch, condoms (male or 
female) or natural cycle tracking. Healthcare providers were also included as a population of 
interest for this study as they act as key agents for contraceptive resources and administration for 
patients whose roles are also integral to patient health identities. Eligible healthcare providers 
were a) English speaking female practitioners; b) that were actively licensed and practicing 
family physicians, OBGYNS, pharmacists or nurse practitioners; c) with experience in 
contraceptive counselling and prescribing within the last 3 months. Female practitioners 
specifically were chosen for recruitment due to the likelihood that they may also have personal 
experience with contraceptive use separate from their professional practice, which may be 
informed or influenced by their work. This ‘shared’ experience with contraceptive use among 
practitioners and patients may act to implicitly bridge social and occupational gaps within 
medical consultations.
3.5 Recruitment
Recruitment for patient consumers and healthcare providers took place from November
2020 through January 2021. Patient consumers were recruited using purposive techniques similar 
to previous studies (Marston et al. 2018) until theoretical saturation was reached. Theoretical 
saturation is a key metric for grounded theoretical approaches wherein sample data is assessed 
simultaneously with data collection measures (Charmaz 2006). Active and immediate data 
analysis following collection acts as a guide for additional sampling until no new themes or 
concepts emerge (Charmaz 2006). Recruitment measures for consumer participants incorporated 
participants from different life stages such as student samples and adult women based in the 
community. Recruitment outreach was exclusively digital due to the unique timeframe of 
conducting research during the COVD-19 pandemic and to ensure the safety of the participants 
and researchers. Consumer patient participants were recruited using digital bulletins and email 
outreach at the University of Saskatchewan through select campus health locations including the 
Student Wellness Centre and University of Saskatchewan Students’ Union (USSU) groups 
including the Childcare Centre and Women’s Centre. Off-campus digital recruitment included 
public health clinics such as Positive Passions, Saskatoon Community Clinic, Saskatoon Sexual 
Health Centre and the Sexual Health Clinic. A total of 18 patient consumer participants were 
confirmed for interviews, however the final number was amended to 17 after one participant 
missed the interview after submitting consent forms and did not elect to reschedule.
Recruitment for healthcare providers involved email circulation through the University of 
Saskatchewan’s College of Pharmacy, Department of Family Medicine, Department of 
Obstetrics and Gynecology, as well as through private clinics such as the Campus Medicine 
Shoppe, Wall Street Obstetrics and Gynecology, Broadway Obstetrics and Gynecology and 
provincial organizations including the Pharmacy Association of Saskatchewan. A total of 5 
healthcare providers consented to the interviews – this included 3 pharmacists and 2 family 
physicians.
No prospective participants were contacted directly by the primary researcher to ensure 
confidentiality of information and freedom of choice. Interested participants were given contact 
details in the email bulletins and Facebook posts to contact the primary researcher, at which 
point they were given additional screening questions to confirm they met the eligibility criteria.
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Once eligibility was determined, participants were invited to schedule an interview date and time 
of their choosing. All participants were given the option of receiving a $20 Indigo or Amazon e- 
gift card of their choosing in appreciation for their time which was sent to their contact email 
used for booking the interview or to an alternative email they provided the primary researcher.
3.6 Interview Structure/Data Collection
Data was collected using semi-structured interviews where patient consumer participants 
were asked about their experiences learning about and using contraception, their resources for 
finding contraceptive information and their perspectives on different contraceptive methods. 
Interview questions were guided by previous literature and incorporated areas previously 
identified as gaps in the research, including the circumstances that led individuals to begin 
contraceptive use and how that use has changed over time. Copies of ads from the content 
assessments as well as a Youtube link to the current Paragard ad campaign were emailed to the 
participants prior to the participant meetings with instructions to simply review the content for 
discussion during the interview. Participants were asked during the interview for their 
perspectives and feedback on the ads. Healthcare participants, in addition to the questions asked 
of consumers above, were asked to provide insight into the trends in contraceptive use they have 
seen through their profession as well as the common contraception questions they fielded in their 
work.
Participants were given the option to have an interview conducted over the phone or
through Webex videoconferencing platform. Two mock interviews were conducted prior to the 
participant interviews, one with a close friend of the researcher and the other with the patient 
partner, to get a sense of the flow of the conversation and to fine-tune any questions for the 
interview guide. While the interview guide was pre-set, the flexibility of the interview structure 
allowed for participants to guide the flow of discussion and allow for probing into particular 
topics or areas of interest that were tangential to the areas of questioning included in the guide. 
The interviews included an opportunity for participants to add any additional points of 
clarification outside of the questions that may be of relevance or importance to the topic. A copy 
of the interview guide can be found in Appendices E and F; copies of the contraception ads can 
be found in Appendix G.
Prior to the interviews, participants were emailed the consent forms as well as the 
contraception ads described above with at least a week in advance of their interview dates in 
most cases to allow time for participants to review the details of the form and ads, and to allow 
for any questions or clarifications to be addressed. The interviews were conducted using the 
Webex toll-free call-in numbers for phone interviews and with added video for videoconference 
interviews. Both phone and videoconference interviews were recorded using the Webex 
recording feature, and with the recording feature of the primary researcher’s iPhone as a backup 
copy. All interview recordings and transcriptions were saved and stored in a password-protected 
university Cabinet account.
All participants were briefed at the start of the meeting regarding the expected duration of
the interview, and reminded that they did not have to answer any questions that they were not 
comfortable with. All participants were made aware that the interviews would be recorded and 
the specific start and stop times for the recordings. Periodic check-ins throughout the interviews 
were done to ensure the participants were comfortable. Options for pseudonyms (researcher or 
participant-generated) or complete identity confidentiality were given in the consent form, as
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well as the option for participants to request a copy of their transcript of the interview. In most 
cases, participants consented to the researcher selecting a pseudonym on their behalf. Where 
requested, participant-generated pseudonyms were used. Two participants elected to remain 
entirely confidential; in these cases, titles such as ‘Respondent’ or ‘Family Physician’ were used.
The interviews were completed over the months of December 2020 and January 2021. All 
but two interviews were conducted over the phone. Each interview lasted approximately 45 
minutes with the range of interview lengths being as short as 30 minutes and as long as 1.25 
hours. All interviews started with a general discussion to build rapport before prior to the starting 
of the recordings. Interestingly, the two interviews that were conducted over Webex yielded a 
longer on-average discussion and a faster rapport compared to interviews conducted over the 
phone. This was surprising, given the fact that phone interviews can afford more privacy and 
discretion when discussing a topic area as personal as contraceptive consumption, and therefore 
could result in greater comfortability in disclosing personal experiences. Before the close of the 
interviews, participants were invited to share any other comments or questions they had before 
the interview was wrapped up and confirmation on their gift card delivery was confirmed. All 
participant email correspondence as well as email addresses used for delivery of the e-gift cards 
were stored in a separate folder form the transcripts in the password protected University Cabinet 
account.
3.7 Transcription and Coding
3.7.1 Data Transcription
Interview data was transcribed using the transcription feature of the University of 
Saskatchewan Webex account. Additional manual transcribing was completed by the primary 
researcher to improve any transcribing gaps and add clarity to the Webex-generated transcripts. 
Transcribing occurred immediately after an interview, in following the process of the theoretical 
saturation (Charmaz 2006). Transcripts were downloaded from the researcher’s University 
Webex account to their campus Cabinet drive and edited using the Notepad application. 
Transcribing between interviews allowed for an informal analysis of the interview data and 
provided an opportunity to make minor amendments to interview questions that were points of 
confusion or required additional clarification during participant interviews. Minor amendments 
included re-wording particular questions to allow for clearer delivery, and to add additional 
prompts to questions based on concepts that emerged from prior interviews. All interviews were 
transcribed exactly as recorded, including pauses, colloquialisms, and filler words (all, umm). 
Interruptions in conversations were also noted. In some cases where the official interview 
questions were completed and the remainder of the interview involved general discussions, this 
content was cut out from the final transcript and indicated in the transcript copy. Where 
requested, transcripts were converted to word documents to be sent to participants requested 
copies.
3.7.2 Coding
The interview data was consolidated and analyzed using NVIVO software. Data analysis 
began with a preliminary read-through of the completed transcripts in order to gain 
familiarization with the data and to note any broad trends or themes. As a complement to the 
initial transcript review and to help parse out content based on the interview questions, copies of 
each transcript were made in Microsoft Word and arranged by inserting ‘headings’ of the
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interview questions. Arranging the transcript layouts by headings allowed for NVIVO to 
autocode the data by these headings and consolidate the responses from each of the participants 
under each heading query for easier analysis and to aid in constant comparison across the texts 
(Charmaz 2006). Following the preliminary read-though of the original and heading-organized 
transcripts, initial coding began with a close read of the data (Charmaz 2006). Initial coding 
followed the first step of grounded theory analysis, where the intent is to follow as closely to 
what appears in the data (Charmaz 2006). I achieved this by using line-by-line coding, and 
coding my data using gerunds, or ‘action words’ to tie the codes to the events exactly as 
described in the data chunks I was analyzing.
With line-by-line analysis, I coded the data by each sentence or thought stream in the 
transcript, and sometimes incorporating an entire paragraph under a single code. Initial coding 
allows for a methodical way to immerse into the data and move outwards from a literal (or 
semantic) interpretation of the data towards a more conceptual (latent) interpretation as 
categories and themes begin to emerge in consecutive rounds of analysis (Braun and Clarke 
2013). It allows for the researcher to get a better sense of the worldviews of the participants and 
the processes at work in their accounts (Charmaz 2006). We first ‘ground’ ourselves in what the 
data is telling us so that we do not get misled in attaching any abstract or theoretical assumptions 
prematurely.
The initial data coding yielded over 200 unique codes. Based on the content of the
interview questions, some very broad categories emerged from the initial coding, such as codes 
related explicitly to the ads (‘Ads’) that participants were asked to comment on, to the role of 
partners (‘Partners’) and doctors (‘Healthcare Providers’) in their experiences with contraceptive 
use. Many passages in the transcripts were initially categorized under multiple codes. This was 
done so that they could be more closely reviewed in consequent rounds of coding and refined 
into a best fit. Most of the codes, however, did not immediately fall into a broad category.
In the second round of analysis, focused coding was employed to closely assess each 
generated code and to begin grouping codes together under emerging categories. Codes and 
excerpts were reviewed and either amalgamated together under an existing code or were re- 
coded to add clarity to the texts. The initial categories that emerged were based on repeated 
concepts or terms that were reproduced over the interviews and guided by the interview 
questions. Refinement and grouping of the codes was aided by recursive analysis of the 
transcripts to ensure the codes and categories were authentic to the contexts of the individual 
accounts. In both the initial and second round of coding, constant comparison across the texts 
was used to ensure thoroughness of the analysis and to aid in refinement of the categories and 
codes. Both processes of focused coding and constant comparison allowed for new references 
and codes to emerge to add ‘meat’ and nuance to the established categories.
The final round of analysis involved theoretical coding. With theoretical coding, the
existing codes and categories are assessed alongside each other to determine the relationships 
and overlapping contexts (Charmaz 2006). In this round, analysis moves beyond the literal 
extrapolation of the participant accounts to the more latent and conceptual meanings behind their 
narratives. Where participants made reference to their bodies ‘adapting’ to the different 
contraception formulas, their systems implicitly ‘knowing’ when to menstruate or their 
understanding of the inner workings of their bodies, these codes merged into the theme of 
“Knowing Bodies”, a refined concept that helped to explain the repeated accounts of implicit and 
explicit somatic knowledge that emerged as a result of contraceptive use. Theoretical coding
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helps us to answer the question “what does this really mean?” in individual narratives of their 
contraceptive experiences. The result of theoretical coding entails a selection of key categories or 
concepts that were repeatedly produced in the participant accounts that relate to one another and 
explain the ways in which contraceptive use and identity play out in individual and social 
contexts.
3.7.3 Memoing
Memo writing is a key hallmark of grounded theory research. Memo writing allows
researchers to document their process and ideas that emerge from their study development, data 
collection and analysis, and can serve as a point of reference and analytical text for data coding 
purposes (Charmaz 2008). Memoing helps to contextualize the reflexiveness and position of the 
researcher in their work and can act as a guidepost for any emerging concepts in the study 
(Charmaz 2006). Throughout the process of my study from development through to analysis, I 
kept a written journal of my observations and reflection on the process. I memoed why I made 
the decisions I did in the development of the research questions, how I determined my population 
of interest and the inclusion/exclusion criteria, as well as my observations on the recruitment 
process. In addition to the Webex recordings, memos were taken during the participant 
interviews (without any identifying data recorded) both for recall later in the interviews, as well 
as to flag any questions that needed reworking or key topics that could be incorporated into later 
interviews.
Memoing was indispensable as an aid to my data analysis and allowed me to track every 
iteration of data analysis by date. I was able to use memoing to record my initial findings and 
thoughts on the data, to ask questions of myself or flag codes for a closer review. Memoing also 
allowed me to identify any gaps in the data or areas for future analysis that fell beyond the scope 
of my study. Memo-writing ultimately served as a journal of sorts to help me understand 
qualitative research and my role in it as observer and participant. Due to the added complexity 
and restrictions of conducting a qualitative study during the COVID pandemic, my memo 
writing was an important methodological tool that repeatedly referred to during data analysis 
alongside the interview transcripts. It helped to formulate and refine categories, to critique and 
analyze the scope and content of the categories, and to explicate the different ways of explaining 
the categories and their relationships. Incorporating the process of initial, focused and theoretical 
coding in conjunction with memo writing, I was able to develop a framework out of the data to 




This section begins with an overview of the emergent framework that contextualizes the 
relationship between consumer identity and contraceptive use. The framework outlined in Figure 
4.1 aims to explicate the different factors that inform consumer identities and consequently shape 
how contraceptives are or are not consumed. Incorporating accounts from interviews with 
seventeen patient consumers and five healthcare providers, the resulting framework describes the 
key social agents and the identity narratives that are reproduced within these social agents that 
directly inform consumer health identities, beliefs, and contraceptive use.
Figure 4.1 – Factors of Influence of Consumer Identity that Impact Contraceptive Uptake
The order of the agents is important; they are listed in ascending order based on their level
of closeness to the immediate social environment of the individuals. Where cultural and media 
sources impact consumer identity on a macro level, their effects are less immediate to the 
consumer’s self-concept; the role of peers and healthcare providers were the most commonly 














a micro level. Interestingly, the roles of peers and providers as contraceptive guides and 
resources were identified as more important to individual self-concept than the role of parents or 
partners. These findings will be expanded upon in later sections.
The concepts of ‘Autonomy’ and ‘Control’ repeatedly surfaced in the discussions with 
consumers and providers. Not only were these terms used directly by nearly all participants when 
describing contraception and its use, but they also fed implicit assumptions about the female 
experience and her relationship with contraception. Taken together, these concepts form the 
primary identity narratives that frame contraceptive use among consumers. The concepts of 
autonomy and control emerged in participant accounts as diametric, or oppositional narratives 
identified as overlapping contexts within the different social agents. The reproductions of these 
didactic identity narratives in social contexts results in a tension at the individual level. The 
process by which an individual negotiates these competing narratives within their respective 
social frameworks consequently informs how they will perceive their reproductive health 
identity and beliefs about contraception and contraceptive use. Table 4.1 below provides more 
detail on the ways in which these identity narratives are reproduced within the different social 








Providers Trusted health partners
Patient and Public Health Advocacy








Supporting Sexual Health Decisions
Trust is key
Controlling Health Behaviours
Conflict and Misalignment 
Discretionary Disinvolvement
Culture & Media Normalizing Contraceptive Use and
Access
Proactive and Productive Women
‘Knowing’ Bodies
The Feminine Contract
Menstrual Body as Problematic 
Sole Sexual Responsibility
Table 4.1 - Conceptual Framework of Consumer Identity and Contraceptive Use
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4.2 Peers
4.2.1 Peers as Key Resources and Method Influencers
Peers were cited by nearly all participants as key first points-of-contact regarding 
contraceptive information and counsel. Peers served as a channel to fill in the gaps with the 
limited early sexual education participants received in elementary schools, or as alternative 
resources to parent figures. Many participants described a comfortability and trust in discussing 
topics like contraception with their friends:
“Yeah, I would say talking with peers feel- felt like; feels like the most safe space, uh, to discuss 
contraception methods. Um, being with people your age who are really accepting, you can kind 
of just talk about anything with them.” (Respondent A)
Participants regularly relied on the experiences of their friends’ contraceptive use to guide their 
decisions on initial contraceptive method starts or method changes. The power of peer-to-peer 
resource sharing was also recognized by healthcare providers. Charlene, a family physician, 
would often incorporate this into her patient counselling by prompting patients to reflect on what 
they already know about contraceptive methods through patient social circles:
“And I think it’s just easier, you know, you do what your friends are on; and that’s usually what 
I ask girls, and they come in and I say ‘Well what have you heard of? What do you know 
about?’” (Charlene, family physician)
The comfortability with using peers as referents for contraceptive information may explain 
patterns of contraceptive uptake among specific demographics and communities. Out of the 17 
participants interviewed, 15 mentioned oral contraceptives (OCP, or ‘the pill’) as either their 
initial or current method of contraception, with condoms (12) and IUDs (3) as the second and 
third most cited methods used, respectively. In cases where participants started hormonal 
contraceptives at a later age (ages 16 and later), many described beginning a method similar to 
their friends or using their friends’ experiences to guide their contraceptive choices. A common 
scenario involved participants expressing interest in shifting away from pill or condom use to 
IUDs. Even before consulting with doctors, participants would refer to their friends’ positive 
experiences with the IUD as an incentive to explore the method further, echoing Sundstrom, et 
al’s. (2016) findings on the effects of peer influencers and LARC uptake. The degree to which 
friend groups factor into contraceptive uptake may explain the reluctance by some in using 
newer contraceptive technology like IUDs. Product familiarity and acceptability among 
participants was always explained in the context of who they already knew that used the 
methods:
“But overall, just because I know a lot of people take the pill; I would rather do the pill.”
(Michelle)
“…I guess, like talk to, like, my friends; uh, a lot of my friends are [sexually] active and I think 
probably half of them are on the pill and use condoms and half just use condoms so like, it seems 
like a good choice.” (Allison)
The accounts of Allison and Michelle describe how the experiences of their friends using 
specific contraceptive methods empowered them to consider the same method for their own 
sexual health needs. Reliance on existing and available contraceptive knowledge among peers is 
worth considering when promoting newer products like the LARC Nexplanon, which was
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recently introduced to Canadian markets. When asked to provide their impressions on the 
Nexplanon print ad featuring actress Vanessa Hudgens, sentiments were overwhelmingly 
negative not only because of its content, but because of its ‘foreignness’:
“Um, I don’t think- just amongst my friend group – I’ve heard of, like, the arm implant, but I 
didn’t really know anything about it. And I don’t really know anybody who does that.”
(Adrianne)
When prompted to confirm if she had previously heard of the contraceptives in the ads, Adrianne 
automatically framed her understanding in the context of her friend groups. These findings place 
the potential for contraceptive uptake to tilt more heavily in favour of experience over 
information or novelty. Despite the creative license taken by advertisers to frame a product in a 
favourable light (celebrity spokespersons, popping text and colour), word-of-mouth was shown 
to be stronger in determining individual perceptions toward a product. Viewed another way, peer 
groups served to polarize beliefs about the acceptability and use of specific contraceptives; 
individuals would adopt this dominant contraceptive discourse into their own beliefs about 
contraceptive types as well as the methods they would and would not consider using.
More than simply method influencers, peers were described as a source of support in their 
shared experience as women and as contraceptive users. Peers were cited as a sounding board for 
commiserating over the less desirable realities of contraception consumption. In cases where 
participants had to grapple with unpleasant side effects associated with their contraception, they 
turned to their friends for advice. A few months after getting a Kyleena hormonal IUD inserted, 
one participant disclosed that she began to experience significant dips in her moods and 
dissociative states. She began to question whether the depressive episodes may be due to the new 
method of contraception, and it was not until a friend mentioned experiencing a similar 
phenomenon with her contraceptive method that her suspicions were confirmed:
“…my roommate at the time, she had been going through a similar experience and, like, brought 
it up that, like, she felt that what I was experiencing was similar to hers; where she just felt like 
really emotional, like the world was ending and shared that same, like, kind of dissociative- 
like…trying her best to do things that made her feel grounded but, like, just couldn’t get a hold 
on it…and yeah, so kind of, from that conversation was like what led me to take mine out.”
(Respondent A)
Perceptions of comfort and security in discussing personal topics like mental health in the scope 
of contraceptive use with peers was a recurring sentiment among participants. When women felt 
seen, heard and validated by their peers, this would feed into individual perceptions of autonomy 
and self-determination in decisions to start or discontinue methods, as experienced by the 
participant above. Comfortability with sensitive topics among friends appeared to increase with 
age and life circumstance – most participants over the age of 30 explained how their ease with 
discussions related to reproductive health and contraceptives increased among peers with the 
onset of major life milestones like marriage or having children.
Conversely, those participants who began using contraception at an earlier age (ages 10-
15 years) served as a referent for their peers for contraceptive expectations. Adrianne, a current 
university student, drew on her early contraceptive education from her parents and her use of the 
pill for acne control to educate her friends once they began using contraceptives at later ages. As 
both contraceptive resources and influencers, peers provide a channel that individuals can draw
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on to inform themselves about the fit of a contraceptive method in their reproductive plans. Peers 
can serve as strong motivators for the adoption or rejection of a particular contraceptive method. 
They provide for women an authentic account of the lived experience as a contraceptive user 
outside of the artifice of a pharmaceutical ad or physician’s office. Drawing on the guidance and 
experiences of peers can be a stronger determinant of individual agency regarding contraceptive 
use outside of healthcare contexts. If a woman has many friends within her group that are using a 
contraceptive, she is more than likely to engage in a similar act, even going as far as to frame her 
expectations of contraceptive use to align with those of her peers. This process of alignment of 
individual attitudes towards contraceptives as well as shared patterns of contraceptive uptake in 
the manner of an individual’s social group lends support to social identity theory (Reed 2002) 
that describes how individuals will adopt cognitive and behavioural strategies to frame their self- 
concept in reference to a particular group membership.
4.2.2 Peers as Deterrents and Cautionary Contraceptive Lore
Peers and peer experiences were also cited as a reason for deterring participants from
certain contraceptive methods. With IUDs in particular, many participants shared secondhand 
‘horror’ stories from friends about negative experiences that predominantly involved the IUD 
insertion process or an IUD failure. Friends’ accounts of the pain and discomfort with having an 
IUD inserted were enough to deter participants from ever considering it as a contraceptive 
option, despite wanting to change their existing method for something more cost-effective and 
less user-intensive. Michelle, a student and childcare worker, shared how her friend had an IUD 
inserted and was “down for the count for, like, 2-3 days…throwing up constantly”; while Kay, a 
website developer, described her friends’ IUDs as ‘shifting’ and causing them internal pain. 
Adrianne recounted how her friend’s mother was using an IUD at the time that she became 
pregnant with her friend. It is likely that the IUDs of that time were far different from the modern 
options available to women today, yet Adrianne remained cautious around considering IUDs as a 
potential contraceptive option. Jenn, another university student, shared a story heard through her 
friends of an IUD getting embedded in the ovaries of its user, resulting in their removal and 
subsequent infertility.
Two participants recalled the Yaz oral contraceptive controversy as a specific brand to
avoid. Dawn, a stay-at-home mother of two, shared how her friend’s use of the Nuvaring resulted 
in her experiencing a psychotic episode that abated once she stopped using it. Narratives 
circulated among peer groups were seen to be more powerful discourses to control the 
perceptions of specific contraceptive methods or brands than even ads; in many cases these 
stories were enough to colour participant perceptions of those methods and remove them from 
consideration in their reproductive plans. Other participants shared general cautionary tales about 
the consequences of contraceptive misuse. Tia, an environmental service worker, recounted 
instances of friends and associates who contracted sexually transmitted diseases (STDs) from 
contraceptive non-use, while another friend experienced an unplanned pregnancy at 16 and 
dropped out of school. In her view, she reasoned that the lingering stigma around contraceptives 
and accessibility issues prevented many of her friends from taking or maintaining consistent 
contraceptive practices and made a point to avail herself to friends in similar circumstances to 
get the contraceptive resources they needed. In this context, peer experiences with contraceptive 
non- or misuse actually served to reinforce participant beliefs about proper and responsible 
contraceptive use:
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“I always preach, um, health and wellness to anyone that I can because it is my passion and, you 
know, I talked to people that I know when I say, ‘Well, do you need a contraceptive? Are you 
safe? Do you use a condom?’ And kids now don't want to use condoms! …But I know people who 
have had intercourse and then wanted Plan B and felt too uncomfortable to go. Of course, I went 
for them because I’m a good person but- I think the stigma around it is debilitating to people.”
(Tia)
Just as their positive experiences shape individual attitudes and intent towards
contraceptive use, so too do the negative experiences of peers. To a greater extent, negative peer 
contraceptive experiences were a stronger predictor of identity disassociation and a controlling 
force in dictating contraceptive method use and behaviours among participants. Despite the 
higher efficacy, lower long-term cost and, in the case of the copper IUD, reduced risk of 
hormonal side effects, many of the participants were unwilling to consider an LARC as a viable 
contraceptive option in part due to the attitudes toward and experiences of the methods among 
their friends. In this way, peer perceptions served as mechanisms of control over both the 
likelihood that a woman would use a contraceptive method as well as the type of contraceptive 
used. In many of these cases, participants often integrate the experiences of their friends into 
their own rationalization for contraceptive use, assuming they will have similar if not the same 
experiences as their peers:
“[speaking about negative contraceptive effects among friends] Yeah, I think if I took birth 
control now, like if I hadn’t been on it before but I started taking it now, it’s something that I 
would maybe even expect to feel just because [of] how common it seems amongst my friends.”
(Jenn)
Rory, a childcare worker, was encouraged by a male friend to take the pill for the first time 
in adulthood, due to her recent shift into a long-term relationship:
“And then, when I have my first serious relationship, is that I have a close guy friends; and then 
he was telling me this:‘You know, my girlfriend [is]actually using those birth control. The long 
term birth control, maybe you should consider to doing now because, uh, you have a stable 
relationship.’" (Rory)
Not only was Rory directed away from non-hormonal contraceptive use (condoms) towards a 
hormonal method, but she was also driven to use this method simply because of a change in her 
relationship status. She attributed her hormonal contraceptive use as a socially-conditioned 
response to her peers, “Because all my girlfriends who has[sic], like, boyfriend…they will like, 
take this.” While it stands that a new relationship may be the impetus for adoption of a 
contraceptive method as some participants described, many of the women in this study turned 
towards contraceptive use for individual health-related reasons. For many, contraceptive uptake 
was a health decision made in consultation with their healthcare providers.
4.3 Healthcare Providers
4.3.1 Providers as Trusted, Unbiased Advocators of Patient Health
In addition to peers, healthcare providers were cited as the primary resource for 
contraceptive information by participants, supporting similar findings in previous studies (De 
Irala et al. 2011; Sundstrom, Szabo and Dempsey 2018). In some cases, doctors were the only
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resource that consumers relied on for contraceptive information and access, adding further 
support to the key partnership that doctors play in contraceptive marketing contexts (Dehlendorf, 
et al. 2017; Sundstrom, Szabo and Demsey 2018). In these circumstances, ‘trust’ and provider 
‘openness’ to exploring treatment options emerged as key attributes in contraceptive 
consultations with healthcare providers:
“I’d probably just call my family doctor because I don’t really trust, like, looking at stuff online, 
just because I know that pharmaceutical companies can sort of, you know, pay to have things 
come up on Google as, like, an ad.” (Jenn)
“[On discussing the Depo Provera shot with her doctor] He was- he’s a fantastic doctor; so he, 
he agreed. He said ‘Yes, this is the best option. Here’s why’. Cause [sic] he’s really open to 
trying new things. So if I would’ve said ‘I want to do this’, he would have, but because I was 
hesitant with, like, an IUD or anything, he agreed that this was the best option for me.” (Wendy)
When women like Wendy and Jenn felt they could trust in their provider and share their health 
questions and concerns in an open exchange, they felt more empowered and in control of their 
health outcomes. Interestingly, these attributes were only mentioned in cases where participants 
had an established family doctor. Where participants started contraception as a treatment for 
medical conditions such as polycystic ovarian syndrome (PCOS) or other significant hormonal 
imbalances, reliability and trust in their doctor was tantamount to their adoption of a 
contraceptive method. In situations where many of the participants started contraception at a 
young age, trust in their healthcare provider was implicit, expected and reaffirmed by parent 
figures.
Despite the expansion of provincial regulations on prescribing authority for Saskatchewan 
pharmacists to include all contraceptive options with the exception of IUDs and the subdermal 
implant, pharmacists were observed to be an underutilized resource for participants. This may be 
due in part to the newness of their prescribing authority, but may also be due to the fact that 
physicians are perceived as having a more comprehensive understanding of patient health 
backgrounds and experiences. In this context, participant trust may be tied to the credentials of 
the healthcare provider, where doctors are perceived culturally as the formative resource for 
health-related matters. Yet the pharmacists in this study indicated an equally similar 
comprehensive understanding of prescription treatment regimens in their experiences with 
patient consultations.
While the pharmacists that were interviewed described the bulk of their contraceptive- 
related patient interactions as predominantly renewals or refills of existing prescriptions, they 
affirmed the value of patient engagement and consultations as foremost in their professions, 
despite consumer perceptions of their work as simply ‘pill pushers’:
“So to me, it discounts the value of our professions - whether you’re a pharmacist or pharmacy 
intern, or physician or nurse practitioner or nurse, or whoever you are, a sexual health 
counsellor - providing information that should go along with this[contraceptive] drug product 
and simply, it just makes it a transaction of a product. Like, there’s the piece missing 
here.”(Lisa, pharmacist)
While Lisa’s comment is in reference to the wording in the Plan B ad stating its availability over 
the counter in the family planning aisle, her perspective can be extrapolated to describe the role
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of healthcare providers foremost as consultative agents and partners with patients in patient- 
centred healthcare settings.
In addition to consulting and prescribing treatments, the healthcare providers in this study 
expressed an openness to improving patient and public health advocacy. Nearly all providers 
described a need for improving sex education in schools and in encouraging patient autonomy in 
seeking contraceptive resources outside of medical consultations. Improving sexual education in 
elementary and secondary schools was shared among participants as well. Where most described 
limited or absent sexual education discussions in their schooling, Tia credited the visiting public 
health nurses that would put on presentations at her high school for supplementing her early 
contraceptive knowledge:
“…[describing the circumstances when she showed up to high school instead of skipping 
classes] I don’t know how I got them, but it would always be when there was some presenter or 
some public health nurse, someone who I didn’t want to see there presenting something. And 
thank God they did, because I always learned so much because I was the only kid that actually 
listened; and the public health nurses coming out and explaining contraceptives, how they work, 
what’s in them. I retain a lot of information from that…I learn from hands-on, talking, 
communicating back and forth.” (Tia)
Tia’s account encapsulates the nuances of individual learning and education around topics like 
sexual health and contraceptive use. Where some individuals gain more value from written 
resources like books and pamphlets, others learn best from hands-on experience or in-person 
discourse. With patients, healthcare providers can utilize both approaches in their consultations 
as a best practice for priming contraceptive awareness and uptake.
In addition to their contraceptive consultations, two of the providers directed patients to 
local health organizations including Out Saskatoon and Saskatoon Sexual Health as well as 
public health sites like the Society of Obstetricians and Gynaecologists of Canada (SOGC). 
Encouraging patient agency in health-seeking behaviours is a hallmark of patient-centered care 
(Dehlendorf et al. 2017; Merz, Czerwinski and Merz 2013) and allows for providers to extend 
their professional resources to further benefit patient health and wellness. Endorsing external 
resources such as the SOGC allows providers to help dispel contraceptive health misinformation 
by guiding patients towards information that is evidence-based and reliable. Using evidence- 
based research and judgement as a foundation for an unbiased and ethical standard of practice 
was cited among all practitioners in this study. As female healthcare providers with a 
professional acumen on contraceptive knowledge and having had personal experience with 
contraceptive use, the providers were clear in communicating that their professional training did 
not allow for personal biases in their consultations. Rather, their individual journeys in educating 
themselves on contraceptives were drawn upon in guiding patients on contraceptive resources. 
This manifested in guidance towards external resources like the SOGC and local health 
organizations, working with patients to determine their health goals, and dispelling patient 
concerns regarding contraceptive effects and use.
4.3.2 Provider Distrust, Bias and Barrier-Making
Of the participant accounts of experiences with healthcare providers (doctors and
pharmacists), many of the interactions were described as neutral or negative. While the providers
in this study described the ways in which they leveraged their knowledge and resources to work
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with patients to arrive at a method to suit their needs, over half of the participants indicated that 
it was the doctors who determined the contraceptive formula for patients with limited guidance 
or discussion on expectations or alternatives. In all of these cases, providers assigned the oral 
contraceptive to patients as a preliminary treatment option or as different formulations in follow- 
up consultations. The automaticity towards the oral contraceptive as a first option for participants 
was reaffirmed among healthcare providers in the context of the method’s popularity in the 
general public; however, providers also indicated a bias towards prescribing methods based on 
previous prescribing experience:
“It’s something they’ve been using for decades, right? So a lot of prescribers are just 
comfortable…We know how to use those medications. We know what the long-term effects are, 
and we can educate people about that. There’s a little bit less unknown.” (Lisa, pharmacist)
As with consumers, providers relied on the pill as a primary contraceptive treatment
option, but framed their preference as based on existing health scholarship as well as their years 
of prescribing experience. The ‘unknown’ in Lisa’s account was in reference to newer 
contraceptive technology like LARCs as a potential explanation for its slow uptake among 
women of reproductive age. Charlene’s explanation regarding pill preference among providers 
and patients may be more telling:
“…I think that’s very, very popular just because it was the first one, so it’s comfortable. As we’re 
experiencing now with the vaccine and stuff for COVID, people prefer things that have been 
around a long time and feel safer with that.” (Charlene, family physician)
Perceived provider bias was apparent with other contraceptive methods including the IUDs. One 
participant recounted an experience with a provider where she expressed an interest in the copper 
IUD but was instead persuaded towards the hormonal version:
“But then the doctor I went to was trying to steer me away from the copper IUD, and she wasn't 
really making it clear why. Just saying, like, ‘I don't like them. Like, the hormonal ones are such 
a low dosage. Like, you don't need to worry about it.’ And, like, I just didn't really know what to 
do in that situation. I felt like I should trust this health care practitioner, so I chose a hormonal 
one.” (Respondent A)
Similar instances of participant discomfort with provider consultations regarding 
contraception were noted. Participants preferred to discuss contraceptive options with general 
physicians with whom they had no prior medical relationship instead of their family physician to 
avoid awkwardness in broaching the subject with a provider that treated them through 
adolescence and with close ties to their family.  In this instance, both discomfort and distrust that 
their physicians would communicate with their families drove participants to seek alternative 
providers. Participant experiences with accessing Plan B were cited as awkward, uncomfortable, 
and interrogatory with pharmacists:
“So it was only $20 to buy it but then it was also $20 to have a consultation with the pharmacist 
who then, like, grilled me on, you know, ‘Do you know what all of your options are for safe sex 
and contraception?’  Like, ‘Were you using condoms-?’ Like, none of your business! Not your 
business! You're a pharmacist, and not even my regular one, I'm not fucking telling you. But like, 
that’s what they have to do, they have to have a consult with you to kind of make you, like shame 
you a little bit.” (Rae)
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While the pharmacists interviewed felt that the consultation requirement for getting Plan B was 
an important and valued opportunity to discuss patient health concerns and safety with its use, 
participants perceived of the consultations as embarrassing, patronizing and a deterrent from 
considering the method again in the future.
The process of accessing Plan B is an example of what many participants described as an 
instance of gatekeeping of contraceptive access by providers. While the Plan B ad referenced in 
the study directed prospective users to ‘find it in the family planning aisle’, this is not actually 
the case in some Canadian provinces, and in Saskatchewan in particular. In one extreme case, a 
participant shared an instance in 2005 where she had to visit multiple Saskatoon pharmacies to 
inquire about Plan B before finally accessing it due to the fact that many didn’t stock it, and in 
one location was turned away for requesting Plan B because the pharmacist refused to dispense 
it. In these instances, control of product availability and consumer access contributed to 
participant perceptions of embarrassment and frustration with contraceptive use. Plan B 
consultations, to participants, were more a means to push a dialogue on proper versus improper 
sexual behaviours by pharmacists more than as a conversation about the product itself. Other 
examples of controlled accessibility involve pharmacy inventories of brand name and generic 
formulations of contraceptives for consumers. While the pharmacists in this study described that 
these decisions were made at a corporate level, it did impact what they were able to fill for 
patients as well as the incurred cost to patients.
Implicit provider bias, distrust and discomfort in provider consultations, and impediments
to contraceptive access were recurring examples of attempts to control the choices for women. 
Limits to communication in consultative settings meant that women had to accept the decision of 
the provider on a contraceptive route or seek an alternative opinion. As many participants cited 
providers as their primary resource for contraceptive information, this put them in a position of 
vulnerability to the inherent power structures of the patient-provider relationship. Regardless of 
provider experience, preference, or bias, this meant that women would settle for a method that 
may not have been a best fit for their health needs, goals, and agency as contraceptive users. As 
some of the participants experienced, incongruencies with some contraceptives led not only to 
feelings of distrust towards their provider, but negatively impacted health identity-related 
perceptions, like Kay’s investigation into her sudden amenorrhea involving multiple pill brand 
changes and a biopsy:
“And then I, because I wasn't having a period, I was like, ‘What the hell's going on? Help me; 
am I dying?’ Like what's going on?... But I will say Oh, sweet Jesus, that I had a terrible 
experience with the gynecologist who was like, ‘Okay, well, I'll just do a biopsy.’ And it was so 
painful, because I don't know if she was just in a bad mood but she made me bleed and it was 
terrible…So I don't know what the hell's going on still, because I'm scared to go back to her, 
because I don't want her to break my vagina.” (Kay)
Or another participant’s worries about herself as a contraceptive user:
“So yeah, it does definitely make me concerned whether there is an option for me or, like, should 
I try this copper IUD? Like, just after this doctor being like, ‘Oh, I don't like it’ and stuff.
So it makes me wonder like, are there negative side effects that I don't want to bring on?”
(Respondent A)
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In these examples, participant perceptions of their bodies as ‘healthy’ bodies were linked to 
contraceptive use. When a misalignment with a contraceptive regimen occurred, some 
participants would not only question the interests of the provider but would question their own 
bodies when side effects arose. This can have the effect of overvaluing the belief of medical 
interventions like hormonal contraceptives as the only viable option for reproductive health 
management.
4.4 Families and Partners
4.4.1 Communication, Collaboration and Support in Families and Partnerships
Parent figures and partners played important roles in consumer health identities and 
contraceptive use, albeit at different milestones in women’s reproductive ages. For some 
participants, parents were credited as supportive and involved in their early contraceptive 
education and use. Mothers assumed a primary role in early intervention and facilitating 
discussions on contraceptive options and scenarios for its use, and as intermediaries in medical 
consultations with healthcare providers. One participant had the benefit of a father who took the 
initiative in educating her on sexual health matters and her contraceptive options. In this case, 
both she and her father shared a medical experience with Accutane use, which for women in 
particular requires simultaneous use of a contraceptive due to the severe fetal development risks 
in the event of an unplanned pregnancy.
Family support was demonstrated in other ways that were tangential to or took the place of 
direct and open discussion. Participants recalled how their parent figures provided them with 
resources like books as a first point of reference:
“...And then more in depth, with a bit more scientific of a lens, my mom gave me, um, a much 
larger book. It was like, 500 pages called ‘Sexy Users Guide’, which sounds intimidating at that 
age, but like I learned best by reading and it also removed a lot of the ‘Oh my God, my parents 
talking to me about sex’; where I could just like, read it and come to her if something didn’t 
make sense.” (Megan)
Engaging with adolescents in ways that encourage them to explore their bodies and sexual 
health on their own terms is a valued tool to build autonomy and self-advocacy at an early age 
(Daley 2014). For participants, providing secondary resources was their parents’ way of 
demonstrating support and engagement in a significant life change as adolescents, but also as a 
placeholder where parent-child discussions about sex and contraceptives were otherwise 
awkward to facilitate. Where there existed a family history of reproductive or menstrual-related 
health matters, participants like Tia could draw on a wealth of experience from the women 
figures in her family that helped her to understand her own reproductive and hormone-related 
issues. In addition to parent figures, participants also relied on extended family members like 
cousins for contraceptive support. Cousins were perceived of as a safer and trusted option for 
contraceptive-related questions and provided a buffer from involving immediate family. The 
benefits of familial involvement with contraceptive education had the effect of priming positive
health-seeking behaviours and autonomy in participants as well as a comfortability in asking
questions of their bodies and health needs in spaces that were safe and supportive.
Where participants began to be sexually active and engaging in relationships, partners 
assumed a greater level of involvement in contraceptive decisions and use. In a few participant
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cases, a new relationship was the prerequisite for contraceptive use at all, a divergence from 
most participant circumstances where contraceptive uptake occurred outside of the scope of 
sexual partnerships and primarily for the purposes of personal health management. For 
participants, open discussion with sexual partners about contraceptive use or non-use was pivotal 
for strengthening the relational connection and for redistributing the responsibility associated 
with healthy sexual behaviours. Expectations surrounding communication and transparency did 
not differ regardless of whether the sexual encounter was transactional (a one-night stand) or 
established as a long-term relationship; however, the level of communication was considered 
more robust within stable partnerships compared to one-time sexual encounters. Partner roles in 
relationships assumed different levels of involvement depending on the maturity of the couple 
and the partnership. In marital partnerships, males shared responsibility in determining 
contraceptive type or took full responsibility by electing for permanent contraception (a 
vasectomy) after family planning had completed.
The extent to which partners engaged in open discussions around sexual health and 
contraceptive use coincided with the perception of trust that participants had in their partners and 
in their shared contraceptive use. Many participants described how they would ‘double up’ on 
methods (using a hormonal contraceptive as well as a condom) in transactional or early 
relationships as a best practice for avoiding STDs as well as the perception of added security and 
comfort afforded from using two methods. Only in cases where trust was established in a 
partnership did participants feel comfortable in discontinuing condom use. The significance of 
removing the ‘barrier’ tied to condom use is twofold: women themselves felt empowered within 
and as a result of their partnerships to forego a method of contraception; and in addition, they felt 
a greater connection and improved sexual experiences while still being protected through 
hormonal contraceptive use. Condom use notwithstanding, hormonal contraceptive use was not 
observed to have a noticeable physical difference in sexual experiences for participants. Rather, 
participants opined the psychological benefit with regularized use of a hormonal contraceptive 
may have a cascading effect on women’s increased presence and engagement in sexual 
encounters (Higgins and Hirsch 2008). Words like ‘protection’, ‘security’, ‘freedom’ and 
‘comfort’ were most often cited among participants when describing their experiences with 
hormonal contraceptive use in sexual encounters. When women felt they had ownership and 
control over their reproductive outcomes, they allowed themselves to enjoy sexual experiences 
more than using no methods outside of situations where women were actively engaged in trying 
to get pregnant.
4.4.2 Parent/Partner Control, Conflict and Disinvolvement with Contraceptive Use
An interesting finding centred on the level of non-involvement of parent figures in 
comparison to the depth of involvement of providers and peers among most participants. 
‘Discomfort’ was often mentioned as a contributing factor to both participant and parent non- 
engagement in conversations about sexual health generally and contraceptive use specifically. 
Participants preferred to explore contraceptives on their own terms or through other channels of 
information before they would consider involving their parents. According to participants, parent 
figures jointly avoided any conversations with their children around sex and contraceptives in an 
act of ‘discretionary disinvolvement’. Alternatively, the responsibility was shifted into the hands 
of the parent considered more ‘hands-on’ in their child’s health matters. Culture played an 
important role in the acceptability of family discussions on topics of sexual health. Participants 
who identified as Chinese, Middle Eastern and Filipina described any dialogue regarding sex and
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contraceptive use as strictly off-limits with parent figures. Sexuality outside the parameters of 
marriage was neither acknowledged nor accepted. Rory credited her move to Canada as the first 
time she was exposed to contraceptives and their widespread use among women outside of her 
family home:
“Like, birth control is not really that common in China, so I only heard about [it] in movies. But 
like, yeah, when I was age 18, when I was actually in Canada and I was like ‘Oh, okay. Actually 
it’s normal for a lady to take this.’” (Rory)
In some circumstances, parent figures employed controlling behaviours around
participants’ health as adolescents. Jenn described how her mother made the decision for her to 
begin contraception at 14 years old. Despite the fact that she was neither dating nor sexually 
active, Jenn perceived her mother’s involvement with her contraceptive use as both a preemptive 
measure in anticipation of her eventual foray into relationships as well as the generational 
trickle-down effect of the sexual health freedoms gained during her mother’s youth. With Rae, a 
social worker and new mother, it was her parent’s religious background that drove their 
reactionary measures to start her on contraceptives at age 15. For her family, the social 
consequences of an unplanned teenage pregnancy were more deleterious than the health effects 
associated with contraceptive use:
“Um, and then eventually when I started menstruating, I got ‘the talk’ because now, like, 
contraception matters or contraceptives matter all of a sudden to my parents. So, yeah, they're 
obviously more concerned about pregnancy than STIs… Yeah, so I grew up in like a 
Presbyterian household so, like, the encouragement was like, ‘We don't have sex until we are 
married’-people; and so not really any discussion around, like sex or contraceptives or like, 
safety until like, I like- literally the day I started menstruating. So, [it] was much more of like a 
reactionary- like a reactive thing, as opposed to being like a preventative thing.” (Rae)
For participants like Rae and Jenn, their initial contraceptive exposure was more consequential to 
the onset of womanhood. Contraceptive use was not interpreted as a mechanism of 
empowerment over their changing bodies; rather, it was viewed as a mechanism of control.
Partner interests would conflict with participant interests regarding prophylactic use. Most 
participants admitted to stopping condom use soon into an established relationship as much as 
for partner comfort as for their own preference. However, some participants described partner 
pressure as a reason for stopping condoms or starting a hormonal contraceptive:
“I don't know, like, actually the reason I got it, an IUD, is because like my boyfriend at the time- 
he wasn't a great boyfriend- he was like, ‘You have to be on birth control’ and so I was like, 
‘Okay, yeah, I can do that.’ And I think that's fair, like, especially because they don't really have 
any other control other than using condoms, like, and those aren't really exactly foolproof, so..”
(Denise)
“Umm, I think mainly is because in Grade 12 I started dating my current boyfriend and we were 
more interested in sex and, umm, then I think it was mainly he was the one who told me that I 
should do it just so it would be less stress and be safer. So, I think it was moreso encouragement 
from him.” (Michelle)
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Partner pressure involved, in cases like Denise’s, explicit requests from partners to start or 
discontinue a contraceptive and/or the implicit responsibility over the comfort level of their 
partner. The perceived responsibility for contraceptive use in partnerships extends further: 
Denise and Michelle validated their partners’ expectations for them to begin contraceptives by 
dismissing the legitimacy of condoms as a safe method of contraception. Denise opined that 
condoms weren’t exactly ‘foolproof’, which is not wrong in scenarios where condoms can be 
used incorrectly; however, this same logic can be applied to all methods of contraceptives 
regardless of pharmacological properties. Like other participants, she simply accepted the 
responsibility of contraceptive use within the partnership.
Anti-condom sentiment and distrust was a common theme among participants, and not 
solely limited to the attitudes of their sexual partners. In the same vein, many participants 
expressed a desire for more male contraceptive options both as an initiative for males to take on 
more responsibility in partnerships and to ‘level the playing field’ experientially for males to 
understand the secondary effects with taking a hormonal contraceptive. Given the prompt of a 
hypothetical scenario where more male contraceptive options were to exist, there was unanimous 
agreement among participants that males would be no more likely to take alternative methods to 
condoms:
“And I think that if- I mean, it's kind of like toxic masculinity as a guy; if a guy's friends find out 
that the guy is taking a pill, how do you think that they're gonna be treated? Or how do you think 
their friends group is going to react? I mean, they want to look all tough and macho and 
everything and, I mean, taking a pill, they're gonna be treated like ‘Oh, like, are you some kind 
of woman?’; like something along those lines.” (Dawn)
These perspectives may be better understood as an outcome of the gendered narratives reinforced 
in larger community and cultural spheres.
4.5 Culture and Media
4.5.1 Empowering and Equipping Women Through Normalizing Contraceptive Use and 
Access
How women internalize messages about sexual health and contraceptive use through social
circles, healthcare bodies, families and partners are all fed by larger cultural scripts and enacted 
through media and advertising. Contraceptive technology advances in North America mean that 
most women can have multiple options at their disposal to manage the nuances of their 
reproductive experiences. All participants in the study had the benefit of knowing someone with 
experience in one or more contraceptive methods that supplemented their own individual 
contraceptive knowledge. No participants described scenarios where they were unable to access 
any contraceptives (hormonal and non-hormonal), and almost all participants cited experience 
with more than one type of contraceptive. Cultural acceptance of contraceptives assumed 
multiple lenses among study participants: as a channel for women to advocate for their bodies, 
health needs and goals; as a metric for personal responsibility for their health decisions; and as a 
tool for understanding their own bodily experiences.
Many women felt that their experiences with contraceptive use led to them developing a 
deeper understanding of their bodies and their menstrual experiences. Where certain 
contraceptives produced unwanted side effects that prompted a switch, women like Dawn, Rae
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and Denise credited their experience with contraceptives for an increased awareness of their 
bodies in relation to hormone-triggered fluctuations:
“When I went off of it, it was just like, profound. I felt like I can feel myself again; like, I was 
connected, my mind and my body were connected, and I lost probably 30 pounds, like fairly 
quickly, like just it's crazy. Yeah, and I just felt so much better.” (Denise)
Similar anecdotes among participants tying their somatic responses to their contraceptive use 
lend support to the idea of ‘knowing bodies’. Women explained that their body would ‘know’ 
when to menstruate when they were taking contraceptives, to stop contraceptives because their 
body ‘needed a break’, and to give hormonal contraceptive use time for their ‘system to balance 
itself out’. In this way, contraceptive use engages a deeper wholistic awareness and 
understanding about women’s somatic selves compared to other consumer products (Watkins 
2012; Wigginton et al. 2016).
Contraceptives, by their very existence, have normalized conversations regarding female 
wellness and sexual health management. Where discussions around periods or pregnancy 
prevention and contraceptive use were formerly relegated to the examination rooms of doctors’ 
offices, the normalcy with which these conversations occur in modern social and public arenas 
has removed any former ‘taboo’ associated with the topic in Western cultures (Tone 2006; 
Watkins 2012). The emergence of longer-acting oral contraceptives and IUDs has also upended 
accepted beliefs about the menstruating body:
“We’re seeing more of a trend, I would say, towards continuous use contraceptives…and that’s 
because a lot of women have realized now – and we know as a medical community - that it’s safe 
to do so.” (Lisa, pharmacist)
This understanding of periods as optional and not necessary was shared both by healthcare 
providers as well as participants:
“I think that girls figured out that, like, if you just keep taking your birth control and you don't 
stop like- if you don't take that week of sugar pills, and you just go into the next one, then you 
won't get your period. So I think they [pharmaceutical companies] kind of figured out that girls 
were maybe just doing that anyways, so they just made a type of pill to adapt to it.” (Jenn)
That contraceptives provide an opportunity for women to unshackle themselves from the 
discomforts associated with a monthly period allow for women to choose how they want to 
calibrate their menstrual experiences. Where participants wanted to automate the occurrence of 
their periods, decrease the volume and duration of their periods, or eliminate them entirely, they 
were able to find a contraceptive to satisfy these health goals.
Contraceptive advertising has historically promoted narratives of empowerment and 
autonomy to prospective users (Kissling 2013; Watkins 2012). However, this study found that 
ideas about autonomy and empowerment were reflected less in the pictorial content of the ads 
and more in the written content. The comprehensive explanation about the Nexplanon implant in 
the ad, while regarded as ‘wordy’, instilled confidence in some participants that they were fully 
informed about the product and its potential effects. Similar explanations were given for the Plan 
B ad: despite being described as simple in appearance, participants appreciated that it explained 
clearly what the product would do, which may help to reframe concerns about emergency
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contraception being an abortifacient (Colarossi et al. 2010). In particular, the messaging in the 
Paragard commercial promoting the ‘hormone-free’ benefits of the IUD is reflective of a new 
social movement towards wellness-focused consumption. Paragard’s messaging was well- 
received more for its non-pharmacological script than the dramatized freedom and independence 
of the actress in the commercial, according to participants. For women with health-related 
limitations for synthetic contraceptives or those that choose to incorporate drug-free 
contraceptive alternatives like Jenn, who by trial-and-error found she experienced significant 
negative physiological effects from synthetic hormones, copper IUDs are being framed as an 
effective and health-conscious alternative to traditional contraceptives.
4.5.2 The Feminine Contract: How Culture Problematizes the Menstrual Body and Assigns 
Reproductive Responsibility
For the majority of participants and providers, the contraceptive ads included in the study 
neither promoted a realistic account of contraceptive use, nor were they considered incentivizing 
as future contraceptive method options. Like Adrianne’s reference to not knowing anyone using 
Nexplanon as a reason for her lack of familiarity with the product, other participants drew from 
social references in their analysis of the Paragard copper IUD commercial. Dawn expressed 
concern that ads like the Paragard commercial were starkly unrealistic to the realities of using 
contraceptives:
“And then you have this girl on here that’s like ‘I got a copper IUD!’; and yes, it is; it has no – 
like – um, hormones in it, but still; like, I know I have friends that have taken IUDs and they’re 
like ‘It was a horrible experience’.” (Dawn)
Within the same vein, the Paragard commercial was criticized for framing their product as 
inherently ‘better’ than hormonal methods while discounting its effects to menstrual cramping 
and bleeding with use:
“The Paragard was kind of cute, but they did talk about some of the side effects, which I thought 
was good, but the one thing they didn't mention is that it can increase menstrual flow in some 
women and I feel like that's a really important one to highlight with the copper IUD; and I was 
actually really surprised that that didn't even come up.” (Megan)
“I feel like a drug ad sort of, well in this case, literally danced around the actual issue…I almost 
never have women who want- they all want lighter periods, or control of their period time or no 
period. Rather than a potentially heavier, potentially more crampy one, the potentially 
additional benefits of having hormones always seem to outweigh the [caveats]-” (Charlene, 
family physician)
Responses towards the Nexplanon ad were predominantly negative, with the majority of 
references criticizing the volume of information and listed side effects as deterring. Healthcare 
providers expressed similar reservations to the message framing of the Nexplanon ad as a 
dissuader for prospective consumers:
“…there was a lot going on. I was like ‘holy smokes’. I don’t know how anyone’s going to read 
this and understand what it’s about. Like, I can barely read it and understand what it’s about.”
(Charlene, family physician)
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While the Plan B ad objectively contained the most explicit references to consumer 
empowerment and agency, some participants took issue with its indirect referencing to female 
responsibility for mitigating unsafe sexual encounters:
“So the Plan B, I think that one is kind of weird because, you know, it takes two to tango…So it’s 
like, you know, it’s like the woman’s responsibility to take care of that. Which I think is kind of 
strange…I think it’s- they’re very directed towards females, and females have to take care of 
their own problems. If they get pregnant by another man, you know, it’s their issue.” (Yolanda)
Plan B’s dialogue of assigned responsibility speaks to a larger cultural issue around 
contraceptives as a whole: that, at the end of the day, contraceptive use is a ‘woman’s issue’:
“Even though I am really good about taking my pill, um, if I forget, the entire burden is on me. 
And there's also been like; sometimes my partner has been a little bit like ‘Did you remember to 
take your pill today? Did you remember? Did you forget? You can't forget! You have to take it!’ 
I don't really appreciate that, like, this implication that I would be like forgetting; because I've 
been on it for so long, that I don't really like that it's an opportunity for like another person to 
kind of pressure me.” (Jenn)
“I, I think what ultimately is most important is that everyone- or, that everyone feels the most 
comfortable; like you shouldn't be persuaded to use a form that you're not comfortable with and 
I guess in that case mostly with women, like, because it's pretty much all on us.” (Respondent A)
Regardless of relationship status, participants described that they felt solely responsible for their 
reproductive fates.
Male responsibility was constrained to condom use in the case of transactional or short-
term relationships and would reduce even further once long-term relationships were established. 
Naturally, participants framed this responsibility in the context the larger biological investment 
required of women: their capacity to carry and bear children, compared to a man’s biological 
investment. That contraceptives have become so deeply gendered may explain this imbalance in 
use among the sexes – as Dawn indicated in an earlier quote, men would be wont to avoid 
anything that could ‘threaten’ their masculinity. A better explanation may be that men would 
avoid anything that could threaten their virility; never mind the fact that women must regularly 
battle the side effects of hormonal contraceptive use, which can also impact their perceptions and 
experiences around femininity and womanhood.
The trade-offs that contraceptive users experience with taking a method of contraception
drive an underlying belief of the menstrual body as problematic. Most participants expressed that
their initial contraceptive use was strictly for health matters and not for use in sexual encounters. 
Common reasons for contraceptive uptake or changes included acne control, reducing cramping, 
regulating periods and lightening periods. Whether expressed or implicit, control was the driving 
impetus over contraceptive use. With the exception of participants exclusively using condoms, 
all other participants using hormonal contraceptives did so with the intention of managing some 
perceived negative aspect around their menstrual systems. Most troublingly, this idea of control 
and management began at the onset of puberty for some participants, like Jenn and Rae. Instead 
of having the opportunity to experience and understand the nuances of her changing body, Jenn 
was primed to perceive her menstruating body as problematic where no problems yet existed:
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“Because I think that my period wasn't that bad at the time; um, I think that I didn't need it that 
badly at the time, although I appreciated what my mom was trying to do for me, I think that I 
would have told- Because I didn't have sex till I was 18, so I would have said, like, ‘Don't worry 
about this until you're actually like, 17, and you actually understand how your body works. Like, 
how do you actually feel? Is your period actually that bad or is it just new?’ So, I think I would 
have maybe just told myself to hold off a little bit?” (Jenn)
With Rae’s experiences with her family’s religious beliefs, a fertile body was a dangerous body, 
because it could mean embarrassment for her family within their community if it was used 
outside of the parameters of religious doctrine.
Perceptions of responsibility and control over their menstrual experiences fed into a larger 
understanding defined as the ‘feminine code of conduct’ – all the ways in which the female 
biological or menstrual experience is enacted and reproduced culturally that women continuously 
negotiate from the onset of puberty and throughout their reproductive lives and
beyond. Conversations around menstruation are almost never spoken of as a neutral experience
but as dichotomized – women either have great periods or they have bad periods. Starting 
contraceptives at a young age was akin to a ‘rite of passage’ for women as they moved from 
childhood into young adulthood. Under this code of conduct, contraception is consistently 
framed as ‘good’, ‘right’ or ‘necessary’ in larger social and health arenas for women to use to 
improve their reproductive functions (Woods 2013). If menstruating bodies are perceived as 
‘messy’, ‘problematic’ or ‘unmanageable’, then promoting the ‘goodness’ of contraceptives 
means framing it as antonym using words and meanings like ‘empowerment’, ‘security’ and 
‘control’ (Kissing 2012; Woods 2013). By consistently reaffirming the value of contraceptives to 
‘improve’ menstrual bodies, women will continue to consume contraceptives even though their 
experiences of their bodies on contraceptives are frequently beset by the same side effects they 
were encouraged to control in the first place. As part of the feminine code of conduct, women 
endure the effects of synthetic hormones on their body out of a duty of responsibility as 
reproductive citizens and because contraceptive-related side effects come at a lower societal cost 




The emergent findings of this study revealed recurring instances of identity-driven
narratives of autonomy and control woven throughout individual contraceptive experiences and 
use shared by participants and providers. At the same time, key social agents were identified as 
having a direct impact on a woman’s identity within the context of contraceptive use. Peers and 
peer groups were observed to have the most direct influence on participant perceptions toward 
and use of contraceptives, while healthcare providers occupied an equally prominent role as 
agents within health systems in helping women to make sense of their health experiences and 
contraceptive uptake. Parents and partners were identified as primary agents of influence, albeit 
at different stages in a participant’s reproductive life. Parents served as an early source for sexual 
health education and acted as intermediaries between their children and doctors, while partners 
assumed a greater role in contraceptive use and healthy sexual behaviours in early and later 
adulthood. Identity dynamics occurring within these social networks are consequently fed by 
larger cultural narratives about gender, sexual health and responsibility that are then enacted 
through media and advertising in a trickle-down approach through each of the channels of 
providers, parents, partners, peers, and to contraceptive users themselves.
This study was undertaken to answer the research question on the ways in which consumer 
identity informs contraceptive use. The findings and resulting theoretical framework address this 
question by describing the process of identity conflict that women engage in with contraceptive 
use. This conflict involves navigating the didactic narratives of autonomy and control as they are 
reproduced in overlapping and tension-creating scenarios within the interpersonal and 
intrapersonal spaces for women. As a result of this conflict, women develop perspectives and 
practices that inform their self-concepts around their health which then dictate their contraceptive 
use and larger contraceptive beliefs. The following sections will examine these concepts of 
identity narratives within the areas of media and advertising, within clinical spaces in provider- 
patient exchanges, and describe the practical and theoretical contributions of the study to 
advance contraceptive consumer research.
5.1 Contraceptive Advertising and Identity Politics
This study examined how identity is framed in contraceptive advertising and how this
impacts consumers.  Many of the criticisms towards DTC contraceptive advertising have centred 
on its unrealistic portrayals of models or spokespersons as well as the message-framing of 
contraceptives as ‘cure-alls’ for the modern ills of womanhood (Kissling 2013; Watkins 2012). 
This study has found that these messages continue to be reproduced in current campaigns, and 
that women are no longer as amenable to the agential smoke and mirrors tactics of 
pharmaceutical advertisers. In the case of the Paragard commercial seizing on the current 
wellness movement in consumer culture, many participants were not convinced of its marketed 
‘superiority’ over hormonal methods. Targeted promotion of niche contraceptive products like 
the hormone-free IUD may have the effect of deterring more prospective users based on its 
explicit identity marketing (Bhattacharjee, Berger and Menon 2014). While having a hormone- 
free contraceptive alternative to condoms is advantageous to users, especially those with pre- 
existing health concerns that would otherwise be restricted for contraceptive options, framing
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Paragard as the only method congruent with consumers of the health-minded, ‘organic’ milieu 
discredits the actual health benefits that can be gained from using hormonal contraceptives.
As Charlene, one of the family physician participants explained, many women start 
contraceptives for the express purpose of mitigating problematic symptoms of their menstrual 
cycles. When she communicated in her patient consultations the main side effect of Paragard as 
increasing cramping and menstrual bleeding, most would opt out of the copper IUD for the 
hormonal version instead. Ads like Paragard and earlier generation campaigns of Seasonique 
(Kissling 2013) and Yaz (Singer 2009; Watkins 2012) can be faulted for their tailored messaging 
– for women looking to ‘free’ themselves from synthetic irritants (Paragard), their premenstrual 
symptoms (Yaz) or their cycles at all (Seasonique) - that either minimizes or omits information 
incongruent to their prospective audience. Contraceptive advertising demonstrates the 
significance of corporate social responsibility (CSR) on the part of pharmaceutical organizations 
in promoting products in ways that are transparent and ethical (Hastings and Saren 2003), and 
yet even current campaigns like the Paragard continue to fall into the grey area of fact versus 
fallacy in their IUD promotion (U.S. Food & Drug Administration 2019)  Decisions on the part 
of pharmaceutical advertisers on striking a balance between marketing and health education 
remain problematic within contraceptive advertising (Ledford 2009), and the Nexplanon and 
Paragard ads in the current study reinforce the precarity of this dynamic.
Nexplanon was criticized primarily for its volume of patient data listing the potential 
contraindications and side effects; this had the effect of being perceived as information overload 
and a scare tactics measure for most participants. However, some appreciated the thoroughness 
of the brand’s explanation, reinforcing the continued dilemma of advertisers in ensuring an ad’s 
‘persuasiveness’ as well as the duty to inform consumers of all reasonable risks with a product’s 
consumption (Ledford 2009). In cases where ads fail to provide enough information for women 
to make an informed decision on uptake of a contraceptive method, they are tasked with 
educating themselves on their reproductive choices or, as all ads mandate, to ‘speak with their 
doctor’. To what end, then, are contraceptive ads ‘empowering’ women to consume their product 
when they direct them to physicians, another agent acting as both gatekeeper of particular 
contraceptive methods and intermediary of contraceptive advertising?
Ironically, contraceptive advertising frames its users as 'independent' and 'in control' of
their bodies and reproductive cycles yet on an implicit level perpetuate the obligation of women 
to 'reign' in problematic features of their biological experience (Kissling 2012; Mann and 
Grzanka 2018). Their menstrual cycles and associated symptoms are viewed as issues instead of 
as a natural variation in their ‘biological homeostasis’, described by pharmacist Lisa, inasmuch 
as cases like scoliosis, allergies or seasonal affective disorder are seen as common health 
aberrations in individuals. This is not to say that those health nuances don't need treatment - in 
many cases they do. Rather, women's menstrual cycles are unilaterally marketed as in need of 
constant control and management, in which case pharmaceuticals are framed as a first and 
primary treatment option. How can a woman, as participant Jenn mentioned, truly be able to 
understand her body as whole when she is immediately referred to contraceptives at first 
menarche?
Contraceptive marketing further clouds this embodied understanding by normalizing the 
continuous long-term consumption of its product as a way to tie women to a medicalized view of 
their body, and to discourage them from stopping their method due to the ‘unknown’ of what 
their body is like without synthetic contraceptives. An interesting finding tied the participants’
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aversion to the Paragard and Nexplanon due to their invasive nature. Most commentaries on 
participant perspectives of LARCs were framed specifically towards their installation and 
removals. The requirement of clinical intervention with LARC may for some women mean that 
their autonomy is being impeded – they have to rely on other agents to ensure their method is 
administered properly, and they must trust the work of the providers to ensure the efficacy of the 
method.
Hormonal contraceptive advertising, unlike condom advertising, routinely promotes its 
product as problem- or risk-mitigating: preventing unplanned pregnancy, reducing menstrual 
cycle occurrences, decreasing PMS; and with LARCs, eliminating daily administration of pills 
and the risk of missing doses. For prospective consumers – especially those primed under the 
expectation to manage their reproductive symptoms - contraceptive advertising promulgates a 
value proposition to control these aspects of their life so they can be better versions of 
themselves, more productive, more engaged in their work and social lives, or more present in 
relationships (Payne, Frow and Eggert 2017). In the ads of for this study, this value proposition 
was reinforced through their use of models and spokespersons. Many of the participants 
described a disconnect between the presence of the spokespersons in the each of the Plan B, 
Nexplanon and Paragard ads. The extent to which the women connected their own experiences 
and knowledge to the ads suggests that typical advertising formulas that utilize ‘flash’, jingles or 
even celebrity ambassadors lack the persuasive power to promote contraceptive uptake.
The findings in this study would suggest that contraceptive advertising re-evaluate the role 
of the spokesperson at all in contraceptive campaigns. Informational content within the ads, 
however extensive or minimal, was demonstrated to be the most beneficial for participant agency 
in evaluating prospective methods, and has been shown in previous studies as a better indicator 
of consumer uptake (Antonishak et al. 2018; Colarossi et al 2010). There is an opportunity to re- 
evaluate the medium of contraceptive advertising holistically. Participants shared that they did 
not engage in print magazines or cable TV as media sources, which may explain the disconnect 
and ambivalence towards the ads used in the study. Rather, peer influence and word-of-mouth 
occupies a higher role in women’s health perceptions and decision-making and may be better 
indicators of their contraceptive uptake (Daley 2014; Sundstrom et al. 2016). Contraceptive 
marketing would be better served by engaging in channels more aligned to the ways in which 
women receive their information by focusing on social platforms like Instagram or TikTok, both 
of which are known for their vast community of social influencers.
Incorporating influencers has been demonstrated to be a more realistic and engaging 
approach to marketing contraceptive consumption and puts more agency in the hands of 
prospective consumers as an external resource for information-gathering outside of clinical 
contexts (Sundstrom et al. 2016). Reliance on influencers, however, does entail risks that can 
include spreading misinformation and polarizing of products. Like the physical ads and 
commercials used in this study, social media faces similar criticisms regarding the unrealistic 
portrayals of its users; influencers in particular can produce more harm than benefit when their 
content is heavily edited and reconstructed into images that perpetuate unattainable social 
‘ideals’. Issues of representation can also arise when involving influencers. Relying on 
influencers that fall within the gender binary diminishes visibility and invalidates the experiences 
of individuals that identify as non-binary or gender fluid. As some participants remarked, the 
explicit gender scripts used in contraceptive marketing becomes problematic when considering 
users that do not subscribe to traditional symbols associated with femininity – examples of this
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would include ad models wearing dresses, makeup, etc. For these reasons, care and intention 
towards aligning with influencers that are sex- and body-positive can help to mitigate some of 
the risks of online promotion and dissemination of contraceptive marketing resources using lay- 
friendly language and platforms that are more accessible to prospective users and the public.
5.2 Provider-Patient Exchanges in Health Marketing Contexts
This study explored the ways in which healthcare providers influenced consumer health 
identities and contraceptive use. The findings have shown that the provider-patient relationship 
was a significant indicator of contraceptive uptake at all among women. Physicians were 
described to occupy a more significant relationship to participant health identities than parents or 
partners. The depth of provider involvement in participant decisions surrounding contraceptive 
uptake supports what has been found in previous studies (De Irala et al. 2011; Sundstrom et al. 
2018), however the findings have shown that perceptions regarding the nature of this 
involvement differed among participants and providers. Most participants described their 
exchanges with healthcare agents as one-sided, where the provider determined the contraceptive 
regimen. However, providers described patient consultations as a more open discussion with a 
prioritization towards patient goals and interests in their prescribing practices. These findings 
suggest that there may be a disconnect between consumer patients and providers in perceptions 
of consumer agency in contraceptive consultations.
One explanation for this may point to the fact that many of the participants started 
contraceptives in early adolescence. In some participant cases where early sex education was 
absent in school settings or through parent figures, providers served as the first point of exposure 
to contraceptives. Naturally, adolescents would defer to the experience and knowledge of a 
physician for most health matters, including sexual health education. This early priming to ‘trust’ 
in healthcare providers would be the product of social conditioning as well as positive 
reinforcement by parent figures that were involved in their child’s health. Conversely, trusting 
provider decisions may have occurred as a result of parental non-involvement in adolescent 
sexual health decisions, and may have served as placeholder for a dependable adult resource 
(Daley 2014).
The risk with physician-led consultations and patient dependency is revealed in perceived 
biases on the part of the provider that result in impediments to communication and collaboration 
with patient consumers on a best fit for their reproductive goals. Provider bias in this study 
emerged as a result of prescribing experience, product knowledge, and patient-centred biases. 
Provider deference to a particular formulation like oral contraceptives was described as a reflex 
of sorts, based on previous prescribing experience as well as comfort in product familiarity. This 
familiarity is inevitably reproduced socially in a woman’s interpersonal relationships by way of 
family members and friends using similar methods, and then within women themselves. The risk 
here lies in effective reproducibility of patient outcomes by providers based on a bedrock of 
evidence-based research and occupational experience, however the patient’s experience of the 
consultation and the product are misaligned to that of the provider’s. They trust in the 
recommendation of their provider and are disappointed when their contraceptives result in 
unwelcome side effects that overshadow the communicated benefits of the product. Provider 
perceptions of patient knowledge can also introduce bias and impact the efficacy of their 
consultations. When patients are perceived as unfamiliar with contraceptives, providers will
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adjust the depth and volume of information they communicate or fall back on reliable scripts, 
just as one of family physician mentioned, “I kind of run through the same spiel every time”.
One of the dominant critiques among women was the perceived lack of additional 
guidance and resources from their providers in clinical settings. This absence of additional 
resources and support produced perceptions of an ‘information poverty’ among participants. 
Reliance on clinical formalities and scripts can be helpful in ensuring a balanced level of care 
among patient interactions, but this can create gaps in understanding of unique patient 
motivations and patient-held knowledge around sexual health supports. In circumstances where 
patient backgrounds involve different geographical or cultural upbringing as some of the 
participants in this study shared, this adds additional complexity to the knowledge-transfer in 
provider-patient relationships and increases the risk of power imbalance in this relational context 
(Adams et al. 2019; Colarossi et al. 2010; Higgins et al. 2016; Meier et al 2019). Additional 
roadblocks may present in clinical consultations where physicians use language or resources 
framed in a heteronormative discourse. Where patients may not identify within the gender 
binary, framing contraceptive discussions within the parameters of ‘female effects’ or 
experiences can result in a disconnect between stakeholders and create conflict in finding a 
solution that fits the patient-specific goals and needs for their reproductive health.
It is when this misalignment of outcomes occur that women describe their encounters with 
healthcare providers with ambivalence or distrust (Higgins et al. 2016). If women like the 
participants in this study place a significant value in providers as shared decision-makers in their 
reproductive health goals, it should stand that women would occupy a shared stake in 
contraceptive consultations. When viewed through a marketing lens, providers act as 
intermediaries for patient consumers to unpack social and cultural messaging surrounding health 
and wellness (Adams et al. 2019; Higgins 2016). They exchange more than prescriptions, but 
also ideas about what it means to be healthy and how to embody and enact culturally relevant 
health rituals (McCracken 1986; Vargo and Lusch 2008). This piece – exchanging ideas – in 
provider-patient relationships appeared to be missing within many participant accounts in this 
study. Participant perceptions of agency in physician-patient relationships were tied to the belief 
that they felt seen, heard, validated and supported in consultative settings around contraceptive 
use. When perceptions of patient-held agency were absent, women resigned to the 
recommendations of the provider or changed providers. Cooperation is replaced by 
acquiescence, and acquiescence results in dissatisfaction with a contraceptive method and 
discontinuation in use.
One consideration for the information poverty experienced among participants include the
fact that many of the participants did not see their family physician or even a specialist OBGYN
for contraceptive counselling. Patient embarrassment and distrust deterred some participants 
from approaching their own family physician based on their relationship to the participant’s 
family.  The risk to patients in seeking an alternative provider for contraception instead of their 
family doctor may be a consultation that lacks the depth of the patient’s health history that their 
family clinic would have; this may subsequently impact the suitability of the contraceptive 
method that is prescribed. Patient reliance on general physicians for contraceptive resources may 
also impact patient agency and the quality of consultation. The depth of patient concerns and 
inquiry into contraceptive options may extend beyond the time constraints of a typical clinical 
appointment.
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Positive provider experiences were affirmed in participant contexts involving a dedicated
family doctor or provider with close ties to their family, or in clinics specializing in sexual health 
and wellness. Family provider relationships served as clear examples of the value in patient- 
centered healthcare in the context of contraceptive uptake. Hallmarks of patient-centred care 
involve open communication between patients and providers, collaboration on health goals, and 
support and empowerment for patient-led decisions (Dehlendorf et al. 2017; Merz et al. 2013). 
Compared to more serious health conditions like cancers or heart disease, reproductive health 
management should be considered the one health topic of which patients are their own experts. 
Contraceptive counselling involves one of the few instances where patients have even a basic 
understanding of their somatic experiences to inform its uptake. Contraceptive use, by extension, 
is one of the best opportunities to extend patient-centered care within a marketing framework of
service-dominant logic (Merz et al. 2013; Vargo and Lusch 2008).
Provider involvement in consumer health identities can extend beyond their prescribing
capacity to a resource-based capacity where information is prioritized as the first level in a multi- 
tiered approach to reproductive health management. Physician and pharmacist roles are 
predicated on improving the human condition using a framework of diagnostic applications to 
identify health problems and generate solutions incorporating (predominantly) pharmacological 
intervention. Improving individual perceptions towards and consumption of contraceptives could 
be redirected away from symptomatizing women’s menstrual experiences and instead educating 
women about the variability of their menstrual biology as a first response by providers. 
Encouraging a space of exploration instead of diagnostic and risk mitigation strategies could 
have the effect of a proactive shift in female perspectives about their reproductive identities and 
accountability towards their health versus current reactive approaches. The findings support an 
opportunity to re-calibrate patient consultations by adding more tools to encourage patient 
agency and confidence in discussing their reproductive needs (Dehlendorf et al. 2017; Merz et al. 
2013). The providers in this study expressed an openness to facilitating patient and public health 
agency by directing patients to local sexual health organizations and equipping patients with 
external evidence-based resources including lay-friendly contraceptive pamphlets and 
government-based public health sites like the SOGC. Leveraging knowledge resources in a 
collaborative context with patients shifts the role of providers as purveyors of a good 
(prescriptions and treatments) to purveyors of a service (knowledge transfer, promoting local 
supports and agency-building) (Vargo and Lusch 2008).
This study found that pharmacists were objectively underutilized as contraceptive
resources, except strictly as accesspoints for contraceptive products. Pharmacists were rarely 
cited as a supportive agent in participant experiences with contraceptive access so much as they 
were impediments to contraceptives, as has been found in previous studies (Johnson et al. 2010; 
Sanabria 2014). This under-reliance was tied to access protocols for emergency contraceptives as 
well as participant misconceptions about the value of pharmacists in the medical care cycle. 
Pharmacists have been shown to be key agents for contraceptive knowledge and supplemental 
prescribing bodies in other jurisdictions (Farris et al. 2015; Maderas et al. 2008; Sanabria 2014), 
and yet many participants in this study were not aware of or convinced of their legitimacy as 
alternative health partners.
Intervention methods like the counselling requirement for Plan B in Saskatchewan
pharmacies are often perceived as patronizing on the part of pharmacists in advising patients on
healthy sexual practices. Where the value is intended on connecting with and educating patients
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on contraceptive methods as the pharmacists in this study have described, women may find that 
this consultation is an ‘overstep’ by pharmacists as infringing on patient confidentiality, where it 
is more accepted in physician clinics. Pharmaceutical barriers do remain an issue among 
contraceptive users, but more in the context of limitations to specific brands or generic 
formulations (Sanabria 2014). While the pharmacists in this study have described the inventory 
decisions occurring at a corporate level, this does raise potential issues to consumers in terms of 
ease of accessibility for preferred brands. In scenarios where clinics and pharmacies are joined, 
there is an opportunity for business to bleed even further into contraceptive consultations where 
clinicians and pharmacy managers may collaborate to drive purchase trends towards specific 
methods (Padamsee 2011). At present, no literature is known that has explored this phenomenon 
in Canadian contexts; however the risk to patient consumers in further commodifying sexual and 
menstrual regulation may have consequences to social initiatives for encouraging healthy 
reproductive behaviours (Hastings and Saren 2003).
Women may also be unaware of the recent expansion in prescribing authority for 
Saskatchewan pharmacists to include contraceptives. Pharmacists can help to bridge the 
informational gap that women experience in physician consultations. Including pharmacists in 
patient-centred care frameworks enhances consumer agency by providing another reputable 
channel to seek contraceptive resources and products. Pharmacists can also continue the medical 
service model by extending the knowledge-transfer of physicians as well as reorienting patients 
towards evidence-based resources (Maderas et al. 2008). In cases where women do not have a 
dedicated family doctor or experience barriers in securing physician appointments, pharmacists 
can serve as a more accessible and less intimidating healthcare agent that can help women to 
arrive at a best fit method or provide them with a temporary solution while they wait to meet 
with a physician. Contraceptive marketing research would gain value from exploring the 
relationship between physicians and pharmacists as healthcare partners in promoting 
contraceptive uptake as a larger public health initiative.
5.4 Contributions
This study contributes to advancing an agenda for contraceptive marketing that is 
transformed from a commodity framework to a public health framework. The findings have 
shown that women begin, end or change contraceptives for uniquely individual reasons that are 
at the same time socially motivated. Contraceptive marketing involves a complex dynamic of 
interpersonal and intrapersonal factors that inform the very essence of what it is to be 
biologically child-bearing. Consuming contraceptives is an act of intention to improve or 
advance one’s health. The social consequences of contraceptive uptake, good and bad, are too 
significant to relegate to simply a medicine cabinet product in the eyes of marketers. This 
research can lay the foundation for a social marketing agenda that can marry the promotional 
incentives of a marketing strategy with the policy initiatives of a public health infrastructure.
Contraceptive use is not solely a ‘woman’s problem’; its existence and use impacts men
and women; communities and cultures. A first step would be to re-evaluate contraceptive ads to 
refrain from isolating promotion in gendered ways and increasing the transparency of 
contraceptive information. Public health organizations have done the work of framing 
communications to reach wider audiences and to make health issues a peoples’ issue instead of 
any single group issue. Redistributing the responsibility of reproductive health decisions can help 
to remove the reproductive burden placed on women from the time they begin menstruating until
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they reach menopause. Understanding the ways in which women are interpreting marketing 
messages around contraception will better equip healthcare providers to approach patient 
consultations with a better sensitivity to the unique motivations and needs of prospective users. 
Involving pharmacists and local sexual health organizations helps to broaden the scope of 
reputable resources for contraceptive information and increase consumer agency in decisions 
around their reproductive health and consumption habits.
Practical contributions could involve overhauling contraceptive advertising away from 
traditional formulas and towards social marketing mixes that incorporate gender neutral language 
and more transparency in product information. References for consumers to ‘speak with their 
doctor’ should be expanded to ‘healthcare provider’. As this study and others have shown, there 
is often more than one agent involved in reproductive-health related decisions; and opening the 
resource channels to more than one healthcare provider empowers consumers to make their own 
decisions on whom they wish to involve and entrust with their health choices. The findings can 
be useful in clinical settings in the form of a patient support guide that can place contraceptive 
use in realistic social contexts as a companion piece to medical reference documents. Helping 
women to understand that their contraceptive choices may be fed by more than one source may 
encourage reflection on the meanings behind their reasons to start a contraceptive regimen. 
Alternatively, this text could be valuable for parents and educators as support tool to enhance 
discussions around contraceptive use with adolescents.
Theoretical contributions could involve advancing the work of Vargo and Lusch (2008) in 
promoting a service-dominant logic marketing framework by placing contraceptive promotion 
into an informational, resource-centred context instead of an end-user transactional process. 
Accessing and consuming contraceptives involves more than simply an exchange of goods, and 
incorporates an overlapping network of shared knowledge, attitudes, and ideas surrounding what 
it means to use contraception. It is a consumption method that requires an exchange of 
experience and perspective from providers and consumers, and this process of knowledge 
exchange continues in a cyclical process back into research, resources and development of the
product. To put it succinctly: contraceptive use does take two to tango, and this involves more
than just sexual partners. The embodied experiences and perceptions of users are critical to 
advancing its uptake among larger populations; in this context, a service-dominant logic 
involving consumers as primary stakeholders is a realistic strategy for contraceptive marketing 
and engages communities in meaningful ways to drive change in empowering large-scale healthy 
sexual behaviours and decisions in populations.
5.4 Limitations
The COVID-19 pandemic caused some time-delays in receiving ethics approval for this 
research, which had the effect of shortening the timelines to complete participant recruitment, 
data collection and data analysis. Due to the social-distancing measures in effect, recruitment and 
data collection had to be restricted to remote settings only. Thankfully, this did not appear to 
impact recruitment interest for patient participants, but it did limit participant interviews to phone 
or videoconferencing options only. As previous studies have demonstrated, exploring a 
decidedly personal and intimate phenomenon like contraceptive consumption has a paradoxical 
effect of bringing women together to connect on tales and trials on their respective contraceptive 
experiences.
54
Healthcare providers were more difficult to recruit, which may have also been due to the 
increased volume and burden on healthcare infrastructure due to the ongoing pandemic. In spite 
of this difficulty with recruitment, this research was strengthened by incorporating the 
perspectives of both patient consumers and providers in a marketing context to better understand 
contraceptive consumption where previous studies limited their focus to one of these 
populations. While phone interviews had the benefit of allowing participants increased comfort 
in sharing their experiences from the safety of their homes, not having the opportunity to develop 
an in-person rapport may have impacted the richness in detail of the personal accounts 
volunteered by participants. Where participants elected to a videoconference interview, however, 
the participant-researcher connection was quicker to coalesce, and conversational flow and detail 
was successful in spite of the lack of in-person settings.
This research project is specific to the contraceptive experiences of this sample of 
participants. The patient participants were a largely homogenous sample – they were fairly 
similar in age ranges and education levels. The healthcare providers in this study were very 
similar in age and years of experience in their respective fields, where all but one described 
themselves as fairly new to their professions with approximately two years’ experience on 
average. While this is advantageous to understand the perspectives of next generation providers 
with regard to patient-centered healthcare, these perspectives may differ from providers with 
many years of experience with different contraceptive formulations.
This study was intentional in its focus on women and the female experience; as a result, the 
findings are not generalizable to the broader population. However, this research has 
demonstrated an opportunity to re-evaluate contraceptive marketing and advertising by 
incorporating messaging that is gender-inclusive, similar to the approach of public health 
campaigns. This research can also be used an opportunity to further research into male- 
administered contraceptives so that the burden of responsible healthy behaviours can be balanced 
among sexual partners. Finally, this research was undertaken with the purpose of exploring the 
ways in which consumer identity informs contraceptive use, how this is enacted through 
advertising, and how social agents influence identity-congruent contraceptive use. This research 
was specifically focused within the context of individual experiences and accounts that impacted 
contraceptive use. The findings have demonstrated that this exploration has been fruitful, and 
that there are takeaways that can inform both healthcare and marketing contexts within the realm 
of reproductive health and pharmaceutical consumption.
5.5 Future Research
This proposed framework has the potential to be incorporated into future marketing 
strategies in both health and general consumer contexts. While it was developed within the 
discipline of consumer behaviour and pharmaceutical marketing, this framework can be used to 
identify the overlapping interpersonal and intrapersonal dynamics that inform individual beliefs 
and intentions around different health consumption practices. The significance of peer influence 
on contraceptive use bears exploring in channels that are more congruent to peer-to-peer (P2P) 
commerce, such as online communities and social media platforms like Instagram, YouTube and 
TikTok. Exploring how influencers promote health identities by way of products like 
contraceptives will broaden understanding of the different social environments in which a social 
marketing approach for contraceptive uptake could be advanced.
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While beyond the scope of this current research, there is a critical need to explore 
contraceptive use through an Indigenous lens. The level of care and sensitivity required to 
engage with Indigenous communities to understand contraceptive meanings and use requires a 
dedicated study. Nor was it perceived of as appropriate for a white middle-class woman 
researcher to assume the role as keeper and disseminator of Indigenous narratives tied to sexual 
health and reproductive identities without considering the historical and enduring systemic and 
discriminatory health practices that continue to affect Indigenous women. It is important to 
understand how Indigenous women perceive of and engage in contraceptive use, especially as 
LARCs continue to be advanced as the next promising generation of contraceptive technology 
considering their bloodied history with the Dalkon Shield and similiar sterilization measures on 
minority and disenfranchised groups.
56
CHAPTER 6: CONCLUSION
Contraceptive use is a unique consumer product in that it is framed as an individual and
private method of consumption yet continues to be marketed as a mass consumer product using 
traditional advertising formulas. Having evolved from its formative pharmaceutical use as a tool 
for preventing unplanned pregnancies, women now use contraception for reasons other than 
simply fertility management – for aesthetics, menstrual regulation, mood and hormonal 
management, or as part of a treatment regimen for medical conditions like PCOS or 
endometriosis. Individual decisions to use contraception do not occur in a vacuum; they are fed 
by overlapping social dynamics. Contraceptive uptake is impacted by political, environmental 
and cultural phenomena; and inversely, contraceptive use in and of itself can have larger 
medical, economic, environmental, social and cultural impacts (Hill 2019; Tone 2006). This 
means that discussions around contraceptive marketing, access and use must be approached as an 
ethical consideration beyond simply as a consumer product. Understanding how individuals 
perceive of contraceptives and why they make the decisions they do around contraceptive uptake 
can help to reorient contraceptive marketing from a traditional advertising mix to a public health 
approach.
This study was undertaken to explore the relationship between consumer identity and 
contraceptive use; how user identities are constructed in contraceptive advertising and this 
impacts consumers; and the ways in which social agents like healthcare providers influence 
consumer health identities and contraceptive uptake. Semi-structured interviews were conducted 
with seventeen community-based participants and five healthcare providers to gain a better 
understanding of the intrapersonal and interpersonal dynamics that impact consumer perceptions 
of contraceptives and decisions to incorporate contraceptives into their reproductive plans. Using 
a grounded theoretical approach, the findings resulted in a theoretical framework that outline the 
key social agents and identity narratives that are reproduced within these social agents that 
directly inform consumer health identities, beliefs, and contraceptive use.
Peers, healthcare providers, parents and partners were identified as primary social agents
that informed consumer health identities and contraceptive use; each of these social agent groups 
are fed by larger cultural scripts that are enacted through media and advertising. The concepts of 
autonomy and control emerged in participant accounts as oppositional identity narratives that are 
reproduced within the levels of each social agent and result in a conflict that women must 
negotiate. As a result of this conflict, women develop perspectives and practices that inform their
self-concepts around their health which then dictate their contraceptive use and larger
contraceptive beliefs. The findings present an agenda to pivot contraceptive marketing away 
from traditional advertising strategies to a social marketing approach that incorporates 
stakeholders including healthcare providers and public health bodies in promoting transparency, 
ethicality, and consumer agency in contraceptive use.
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Appendix A: Ethics Approval Certificate
Appendix B: Participant Recruitment Memo
Department of Management & Marketing
University of Saskatchewan
PARTICIPANTS NEEDED FOR
RESEARCH IN CONTRACEPTION MARKETING
We are looking for female volunteers to take part in a study on
contraceptive marketing and contraceptive use.
As a participant in this study, you would be asked to participate in an individual 
interview to discuss your knowledge and experiences with contraceptive options and
contraception use.
Your participation would involve a one-time session that will run approximately 60
minutes (1 hour) in length.
In appreciation for your time, you will receive an e-gift card of your choice for
Amazon or Indigo Books.
For more information about this study, or to volunteer for this study,
please contact:
Tara Lucyshyn
Department of Management & Marketing




This study has been approved by the University of Saskatchewan Behavioural Research
Ethics Board
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Appendix C: Healthcare Provider Recruitment Memo
Participants Needed: Birth Control Marketing Study
Good Afternoon,
I am an MSc. Marketing student interested in exploring contraceptive use, trends and patterns. As 
most contraceptive consumption involves medical intervention, my study intends to include not only 
consumer perspectives but also the knowledge and perspectives of healthcare providers.
In addition to consumer perspectives, we are also looking for providers such as doctors, OBGYNs, 
pharmacists or nurse practitioners to take part in in the study as key intermediaries for contraceptive 
resources and access.
As a participant in this study, you would be asked to take part in a telephone or video interview 
session of approximately 60 minutes to describe your knowledge and experiences with 
contraception resources, contraceptive methods and access and how these elements inform your 
patient consultations.
In appreciation for your time, you will receive your choice of an Amazon or Indigo Books e-gift card 
for your contribution.
To be eligible to participate you need to be female, a licensed family physician, OBGYN, nurse 
practitioner or pharmacist with experience in contraceptive counselling and prescribing within the last 
3 months.
If interested, please contact:
Tara Lucyshyn, MSc Candidate, Edwards School of Business
tara.lucyshyn@usask.ca; (306) 966-7138
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Appendix D: Participant Consent Form
Participant Consent Form
You are invited to participate in a research study entitled: Birth Control Embodied: How 
Identity Drives Contraceptive Use
Student Researcher(s): Tara Lucyshyn, Graduate Student, Department of Marketing & 
Management, Edwards School of Business, University of Saskatchewan; phone: (306) 966-7138; 
email: tara.lucyshyn@usask.ca
Principal Investigator/Supervisor: Dr. Marjorie Delbaere, PhD., Associate Dean Research and 
Faculty Relations, Edwards School of Business, University of Saskatchewan; phone: (306) 966- 
5916; email: marjorie.delbaere@usask.ca
Purpose and Objective of the Research:
•  To understand what reasons and factors go into choosing and using a contraceptive method
(the pill, the IUD, condoms, etc.)
•  To explore how individual and social factors impact contraceptive method use or non-use.
•  To examine what attributes individuals value when making decisions on using a method of
contraception
Procedures:
•  Data will be collected from individual interviews
•  Interviews are expected to run approximately 1 hour in length
•  Interviews will be conducted remotely via Webex videoconferencing or over the phone
•  All interviews will be audio/video recorded (video recording will be done only in the case of
Webex interviews); participants may request that the recorder be turned off at any time 
without giving a reason
•  Interview recordings will be transcribed by the student researcher
•  Please feel free to ask any questions regarding the procedures and goals of the study or your
role.
•  Participants will have an opportunity to view and make revisions to their transcripts, which will
be made available within 7 days of the interview date. Participants will have until February 28,
2021 to submit any revisions to their transcripts. If no revisions are received by February 28,
2021, the data will be used as it was initially transcribed.
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Funded by: Saskatchewan Centre for Patient-Oriented Research (SCPOR)
Potential Risks:
•  There are no known or anticipated risks to you by participating in this research.
•  Participants will receive a copy of this form stating the goals of the study and all the relevant contact
information for future inquires.
Potential Benefits:
•  Expanded understanding on different contraceptive methods, technology and contraceptive
benefits
Compensation:
•  You will receive a $20 e-gift card of your choice of Amazon or Indigo Books for your
participation in the study. The e-gift card will be sent to the email address you provided to the
researcher.
Confidentiality:
•  The data from this research project will be published and presented at conferences; however,
your identity will be kept confidential. Although direct quotations may be reported from the 
interview, you will be given a pseudonym, and all identifying information (e.g. your workplace) 
will be removed from the report
•  Results will be used in a summary report to the Student Wellness Centre to help enhance
provider-patient consultations regarding contraception, however no participant identifying
information will be included
•  No contact information will be provided to anybody outside of the research team
Please put a check mark on the corresponding line(s) to grant or deny your permission:
I grant permission to be audio recorded
I grant permission to be video recorded
Please only select one option below:
I wish for my identity to be confidential but you may refer to me by a
pseudonym.
The pseudonym I choose for myself is: _________________________
I would like you to choose a pseudonym for me.
Storage of Data:
•  Electronic data will be stored in a password-protected computer and (in the case of phone
interviews) smartphone during analysis, but will be moved to a secured Cabinet system at the
University of Saskatchewan for long-term storage
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•  Physical transcripts will be stored in a locked cabinet in a locked office
•  Upon completion of the study and post-publication, data will be securely stored at the
University of Saskatchewan for five years
•  Following the five-year storage period, data will be destroyed beyond recovery
•  Data that contain identifying information such as consent forms and participant lists will be
stored separately from the data collected in a password protected computer, and will be 
destroyed once data collection is complete and the forms are no longer required
Right to Withdraw:
•  Your participation is voluntary and you can answer only those questions that you are
comfortable with. You may withdraw from the research project for any reason, at any time
without explanation or penalty of any sort.
•  Should you wish to withdraw,  please contact the primary researcher, Tara Lucyshyn at
tara.lucyshyn@usask.ca to request to withdraw your participation from the project. Your data 
will be fully deleted from the research project and destroyed in a secured setting at the 
University of Saskatchewan campus.
•  Your right to withdraw data from the study will apply until March 31, 2021. After this time, it is
possible that some form of research dissemination will have already occurred and it may not be
possible to withdraw your data.
Follow up:
•  To obtain results from the study, please email Tara Lucyshyn at tara.lucyshyn@usask.ca or
Marjorie Delbaere at delbaere@edwards.usask.ca to receive a summary copy of the results of
the study.
Questions or Concerns:
•  Contact the researcher(s) using the information at the top of page 1.
•  This research project has been approved on ethical grounds by the University of Saskatchewan
Behavioural Research Ethics Board.  Any questions regarding your rights as a participant may be
addressed to that committee through the Research Ethics Office: ethics.office@usask.ca; 306-966-
2975; out of town participants may call toll free 1-888-966-2975.
Signed Consent (on next page):
Your signature below indicates that you have read and understand the description provided.
I have had an opportunity to ask questions and my questions have been answered. I consent to 
participate in the research project. A copy of this consent form has been given to me for my 
records.
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Name of Participant Signature Date
______________________________      _______________________
Researcher’s Signature         Date
Please sign and email a copy of this form to the researcher at tara.lucyshyn@usask.ca. Print 
or electronic signatures will suffice as authorization of your consent. You may keep a copy of 
this consent form for your records.
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Appendix E: Consumer Participant Interview Guide
Patient/ Consumer Interview Questions:
1. Can you start with telling me a bit about yourself, like your first name and what you currently do
(student, worker, stay-at-home parent, etc.)
2. Tell me about the first time you learned about contraception? How did you hear about it? Age?
a. From a person: Tell me about the person you learned this from?
b. From source: Tell me about the source, how you came upon it?
3. When did you begin to use contraception? [Prompt: How soon was this after you first learned
about it?]
a. What method did you use?
b.  How did you decide on that method?
4. What reasons did you start using contraception?
5. Tell me about the role your family or parents have played in your early experiences with
contraception?
6. You were provided with two copies of print ads for contraception and a link to a Youtube link
for an ad for Paragard prior to meeting. Tell me what your first thought/reaction was when you 
first saw these ads. Have you seen them before?
a. What’s your overall impression of the ads?
7. Where would you go to find more information on contraception? [Prompt: web? Doctors?
Friends? Family?]
8. Can you tell me about the last contraceptive method you used? Why did you switch/stop?
9. Tell me about the current method you use. What led you to decide on this method?
a. What do you like about your current method?
b. Consistent use? Any stops or breaks?
c. Is there anything you wish you could change about your current method?
10. What do you like about contraception in general?
a. Is there anywhere where contraception is missing the mark or could be improved?
b. What are your thoughts on the fact that there are so many different contraceptive methods
available to women, but only one method for males?
11. What is your view on the role of partners in decisions regarding contraceptive use or choosing
contraceptive methods in a relationship?
12. Can you describe for me any major myths or rumors you’ve heard about regarding contraception,
or specific contraceptive types?
13.  Some people have reported that birth control use has changed them/bodies/personalities that
they’ve only noticed once they changed/went off hormonal contraception? Have there been any 
instances where you might have noticed changes like this in your own experiences?
14. Some people have found that birth control has made their sex lives better, while others have
found that it’s made it worse and others have found no effect? What are your thoughts on that? 
15. Can you describe for me any challenges/issues that you’ve encountered in accessing
contraceptives or information on birth control/contraceptives?
16. Knowing what you know now at this point in your life, if you had a chance to explain
contraception to your younger self, what would you tell them?
17. Is anything else or any final thoughts you’d like to add?
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Appendix F: Healthcare Provider Interview Guide
For Providers:
1. Can you start with telling me a bit about yourself, like your first name and how long you’ve been
practicing as a healthcare provider?
2. Before you started in your profession, can you tell me about the first time you learned about
contraception? How did you hear about it? Age?
3. In your current role, what are your primary resources for getting information on contraception?
a. Prompt: [Drug Reps? Online Sources? RX Files? Society of Obstetricians & Gynecologists?]
b. With new contraceptive technology and brands coming to market, how do you stay informed
about these new products, as well as new information coming out about existing 
methods/brands?
c. What sources would you say you prioritize as a healthcare provider?
4. You were provided with copies of print ads and a YouTube link for a contraception ad prior to
our meeting. Tell me what your thoughts were when you first saw these ads. Have you seen them 
before? What impressions do you get?
5. What are the top 3 most important things that you prioritize in a contraceptive method in your
role as a provider? [Prompt: in your patient consultations]
6. What are the most common contraception trends/methods that you are noticing right now? Has
this changed in the last year/5 years/10 years?
7. What are the most common questions patients come to you for regarding contraception?
8. What are the biggest myths/rumors you have heard about contraception from patients?
9. What would you recommend for additional resources for your patients when they want more
information on birth control?
10. How have your personal experiences, if applicable, with contraception informed your
interactions with your patients?
Is there anything else or any final thoughts you’d like to add?
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Youtube link for Paragard IUD Commercial: https://www.youtube.com/watch?v=F4Yj6K9vfUc
79
